<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33177214</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2379-5042</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>11</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>mSphere</Title>
                <ISOAbbreviation>mSphere</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">e00827-20</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/mSphere.00827-20</ELocationID>
            <Abstract>
                <AbstractText>Viral shedding patterns and their correlations with immune responses are still poorly characterized in mild coronavirus (CoV) disease 2019 (COVID-19). We monitored shedding of viral RNA and infectious virus and characterized the immune response kinetics of the first five patients quarantined in Geneva, Switzerland. High viral loads and infectious virus shedding were observed from the respiratory tract despite mild symptoms, with isolation of infectious virus and prolonged positivity by reverse transcriptase PCR (RT-PCR) until days 7 and 19 after symptom onset, respectively. Robust innate responses characterized by increases in activated CD14<sup>+</sup> CD16<sup>+</sup> monocytes and cytokine responses were observed as early as 2...days after symptom onset. Cellular and humoral severe acute respiratory syndrome (SARS)-CoV-2-specific adaptive responses were detectable in all patients. Infectious virus shedding was limited to the first week after symptom onset. A strong innate response, characterized by mobilization of activated monocytes during the first days of infection and SARS-CoV-2-specific antibodies, was detectable even in patients with mild disease.<b>IMPORTANCE</b> This work is particularly important because it simultaneously assessed the virology, immunology, and clinical presentation of the same subjects, whereas other studies assess these separately. We describe the detailed viral and immune profiles of the first five patients infected by SARS-CoV-2 and quarantined in Geneva, Switzerland. Viral loads peaked at the very beginning of the disease, and infectious virus was shed only during the early acute phase of disease. No infectious virus could be isolated by culture 7...days after onset of symptoms, while viral RNA was still detectable for a prolonged period. Importantly, we saw that all patients, even those with mild symptoms, mount an innate response sufficient for viral control (characterized by early activated cytokines and monocyte responses) and develop specific immunity as well as cellular and humoral SARS-CoV-2-specific adaptive responses, which already begin to decline a few months after the resolution of symptoms.</AbstractText>
                <CopyrightInformation>Copyright .. 2020 Vetter et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Vetter</LastName>
                    <ForeName>Pauline</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">0000-0002-9902-5069</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland Pauline.vetter@hcuge.ch.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Eberhardt</LastName>
                    <ForeName>Christiane S</ForeName>
                    <Initials>CS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of General Pediatrics, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Meyer</LastName>
                    <ForeName>Benjamin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Martinez Murillo</LastName>
                    <ForeName>Paola Andrea</ForeName>
                    <Initials>PA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Torriani</LastName>
                    <ForeName>Giulia</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pigny</LastName>
                    <ForeName>Fiona</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lemeille</LastName>
                    <ForeName>Sylvain</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cordey</LastName>
                    <ForeName>Samuel</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Laubscher</LastName>
                    <ForeName>Florian</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vu</LastName>
                    <ForeName>Diem-Lan</ForeName>
                    <Initials>DL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Calame</LastName>
                    <ForeName>Adrien</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schibler</LastName>
                    <ForeName>Manuel</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jacquerioz</LastName>
                    <ForeName>Frederique</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Blanchard-Rohner</LastName>
                    <ForeName>G..raldine</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of General Pediatrics, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siegrist</LastName>
                    <ForeName>Claire-Anne</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of General Pediatrics, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaiser</LastName>
                    <ForeName>Laurent</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Didierlaurent</LastName>
                    <ForeName>Arnaud M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eckerle</LastName>
                    <ForeName>Isabella</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>mSphere</MedlineTA>
            <NlmUniqueID>101674533</NlmUniqueID>
            <ISSNLinking>2379-5042</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D056704" MajorTopicYN="Y">Adaptive Immunity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="Y">Viral Load</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017201" MajorTopicYN="Y">Virus Shedding</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">antibody response</Keyword>
            <Keyword MajorTopicYN="Y">cytokines</Keyword>
            <Keyword MajorTopicYN="Y">immunity</Keyword>
            <Keyword MajorTopicYN="Y">viral load</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>12</Day>
                <Hour>5</Hour>
                <Minute>34</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33177214</ArticleId>
            <ArticleId IdType="pii">5/6/e00827-20</ArticleId>
            <ArticleId IdType="doi">10.1128/mSphere.00827-20</ArticleId>
            <ArticleId IdType="pmc">PMC7657589</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Invest. 2020 May 1;130(5):2620-2629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aliment Pharmacol Ther. 2011 Oct;34(8):960-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21848603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Apr 17;369:m1470</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32303495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 May;581(7809):465-469</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32235945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Jun;127:104370</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32344321</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Apr 7;369:m1328</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32265220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2005 Aug;86(Pt 8):2269-2274</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16033974</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2020 Jul 07;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32692346</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jun;20(6):339-341</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32317716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 May;26(5):672-675</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32296168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Discov. 2020 May 4;6:31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32377375</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2014 Sep;52(9):3351-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25009045</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jul 28;71(15):825-832</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32277759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 7;369(6504):718-724</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunology. 2010 Jun;130(2):202-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20113369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011;6(10):e25858</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21998709</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32187464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011 Mar 01;6(3):e17484</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21390263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2017 Mar 13;8:272</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28348563</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Jan;25(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31992387</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Apr;26(4):453-455</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32284614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Jun;26(6):842-844</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32398875</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Jun 25;181(7):1489-1501.e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32473127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Leukoc Biol. 2020 Oct 11;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33040384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2020 Oct;26(10):1386-1394</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32603801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Jun;20(6):656-657</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32199493</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Jun 26;5(48):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32591408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2014 Jul 9;16(1):115-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24981333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Apr 28;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32343429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jun;20(6):355-362</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2019 Mar 5;93(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30626681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2020 Jun 26;38(31):4783-4791</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32507409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2020 Oct;26(10):2494-2497</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32603290</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33176585</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>05</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1651-1905</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>49</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Scandinavian journal of public health</Title>
                <ISOAbbreviation>Scand J Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Is fighting against COVID-19 enough?</ArticleTitle>
            <Pagination>
                <MedlinePgn>9-13</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1177/1403494820969539</ELocationID>
            <Abstract>
                <AbstractText>Tools of empirical epidemiology have been and are indispensable to focus political power on blocking the spreading of coronavirus disease 2019 (COVID-19) by stopping transmission. The present paper is a comment on E. Gibney's article 'Whose coronavirus strategy worked best?' (<i>Nature</i> 2020;581:15-6). The strategy for phase 2 should be more complex and interdisciplinary than described in the paper in <i>Nature</i>, especially in the period before a vaccine and specific treatments are available. The focus on reducing the mortality of COVID-19 will have side effects, including excess mortality from other causes. A part of this excess mortality will be based on the reduction of health-care offers as a consequence of the pandemic, and on structural limitations of the health-care system. A special challenge is to understand the relationship between death <i>from</i> and death <i>with</i> COVID-19, and therefore the relevance of severe acute respiratory syndrome coronavirus 2 infection in people with pre-existing burdens, for example coronary heart disease, cancer or older age. There is a need to extend the recently used tools to all available instruments, including physiological principles of prevention and promotion. The way to integrate global solidarity into the strategies of the different countries is critical not only for global health but also for the peace and long-term success for each individual country. The consequences of efforts against COVID-19 and the impact on reduced air pollution and climate change are also important to analyse from a global health perspective.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kofler</LastName>
                    <ForeName>Walter</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical University of Innsbruck, Austria.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>I.M. Sechenov Moscow State Medical University (Sechenov University), Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Glazachev</LastName>
                    <ForeName>Oleg S</ForeName>
                    <Initials>OS</Initials>
                    <AffiliationInfo>
                        <Affiliation>I.M. Sechenov Moscow State Medical University (Sechenov University), Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lyshol</LastName>
                    <ForeName>Heidi</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">0000-0003-3135-5827</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Health and Inequality, Norwegian Institute of Public Health, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tellnes</LastName>
                    <ForeName>Gunnar</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">0000-0001-5823-9493</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine and Global Health, University of Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Health Sciences, Kristiania University College, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Sweden</Country>
            <MedlineTA>Scand J Public Health</MedlineTA>
            <NlmUniqueID>100883503</NlmUniqueID>
            <ISSNLinking>1403-4948</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>Nature. 2020 May;581(7806):15-16</RefSource>
                <PMID Version="1">32341558</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">NaCuHeal</Keyword>
            <Keyword MajorTopicYN="Y">Nature-Culture-Health</Keyword>
            <Keyword MajorTopicYN="Y">community medicine</Keyword>
            <Keyword MajorTopicYN="Y">health promotion and prevention</Keyword>
            <Keyword MajorTopicYN="Y">infectious diseases</Keyword>
            <Keyword MajorTopicYN="Y">public health</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>12</Day>
                <Hour>5</Hour>
                <Minute>29</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33176585</ArticleId>
            <ArticleId IdType="doi">10.1177/1403494820969539</ArticleId>
            <ArticleId IdType="pmc">PMC7859583</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Swiss Med Wkly. 2020 Mar 16;150:w20224</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32176808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Rehabil Res. 2005 Jun;28(2):175-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15900190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 May;581(7806):15-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32341558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Theor Med Bioeth. 2015 Feb;36(1):61-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25604955</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 1;368(6490):455-456</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32355007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Public Health. 2009 Aug;37(6):559-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19666672</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Alzheimers Dement (N Y). 2017 Feb 08;3(1):114-122</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29067323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2010 Mar;65(3):399-409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20053689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 30;395(10238):1715-1725</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32405103</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618778955</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29857780</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 23;382(17):e37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32237671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cardiol. 2017 Jun;40(6):370-376</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28323322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2020 Mar 11;12(534):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32161107</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33176090</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1533-4406</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>383</Volume>
                    <Issue>20</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Nov</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The New England journal of medicine</Title>
                <ISOAbbreviation>N Engl J Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Audio Interview: An Update from Operation Warp Speed.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e127</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMe2033111</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rubin</LastName>
                    <ForeName>Eric J</ForeName>
                    <Initials>EJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baden</LastName>
                    <ForeName>Lindsey R</ForeName>
                    <Initials>LR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Woodcock</LastName>
                    <ForeName>Janet</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morrissey</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
                <PublicationType UI="D017203">Interview</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>N Engl J Med</MedlineTA>
            <NlmUniqueID>0255562</NlmUniqueID>
            <ISSNLinking>0028-4793</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003256" MajorTopicYN="N">Community Participation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017277" MajorTopicYN="Y">Drug Approval</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004341" MajorTopicYN="N">Drug Evaluation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056747" MajorTopicYN="N">Immunomodulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014486" MajorTopicYN="N">United States Food and Drug Administration</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>17</Hour>
                <Minute>16</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33176090</ArticleId>
            <ArticleId IdType="doi">10.1056/NEJMe2033111</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33175700</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1972-2680</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Oct</Month>
                        <Day>31</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of infection in developing countries</Title>
                <ISOAbbreviation>J Infect Dev Ctries</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19, indications for professional football teams and referees training resumption.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1084-1089</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3855/jidc.13436</ELocationID>
            <Abstract>
                <AbstractText>These indications were drawn up by the Federal Medical-Scientific Commission (FIGC Commission), supplemented for the necessary time by some experts on the subject; currently they are intended to grant the highest achievable guarantee level to protect the health of players, referees and all professionals involved in case of resumption of collective training (Document dated 18 April 2020). They were designed to minimize the risk of contagion were thus based on the fact that during that phase of SARS-COV-2 virus pandemic (COVID-19) and in the absence of an effective vaccine, the zero-contagion risk did not exist and does not exist to date. Those guidelines have been updated on the basis of ongoing medical-scientific evidence, taking into account the indications given by the Technical-Scientific Committee and the opinion of the Italian Football Federation representatives, during a meeting that took place on May 7 and was transmitted to FIGC on May 11, 2020; these indications are to be considered stringent and binding for the purposes of sport training resumption.</AbstractText>
                <CopyrightInformation>Copyright (c) 2020 Matthew Gavino Donadu, Angelo Renato Pizzi, Paolo Zeppilli.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Donadu</LastName>
                    <ForeName>Matthew Gavino</ForeName>
                    <Initials>MG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Commission Referees Technical Sector, Italian Referees Association, Italian Football Federation, Rome, Italy. mdonadu@jidc.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pizzi</LastName>
                    <ForeName>Angelo Renato</ForeName>
                    <Initials>AR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Commission Referees Technical Sector, Italian Referees Association, Italian Football Federation, Rome, Italy. anpizzi@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeppilli</LastName>
                    <ForeName>Paolo</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Scientific Medical Commission, Italian Football Federation, Rome, Italy. paolo.zeppilli@policlinicogemelli.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>J Infect Dev Ctries</MedlineTA>
            <NlmUniqueID>101305410</NlmUniqueID>
            <ISSNLinking>1972-2680</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003666" MajorTopicYN="N">Decontamination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000068958" MajorTopicYN="N">Return to Sport</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012916" MajorTopicYN="Y">Soccer</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000072264" MajorTopicYN="N">Sports and Recreational Facilities</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">football</Keyword>
            <Keyword MajorTopicYN="N">infection</Keyword>
            <Keyword MajorTopicYN="N">prevention</Keyword>
            <Keyword MajorTopicYN="N">protocol</Keyword>
            <Keyword MajorTopicYN="N">referees</Keyword>
        </KeywordList>
        <CoiStatement>No Conflict of Interest is declared</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>17</Hour>
                <Minute>13</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33175700</ArticleId>
            <ArticleId IdType="doi">10.3855/jidc.13436</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33175649</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1758-1095</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>113</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>12</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the Royal Society of Medicine</Title>
                <ISOAbbreviation>J R Soc Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19, seasonal influenza and measles: potential triple burden and the role of flu and MMR vaccines.</ArticleTitle>
            <Pagination>
                <MedlinePgn>485-486</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1177/0141076820972668</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Islam</LastName>
                    <ForeName>Nazrul</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">0000-0003-3982-4325</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Khunti</LastName>
                    <ForeName>Kamlesh</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Leicester Diabetes Centre, University of Leicester, Leicester LE5 4PW, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Majeed</LastName>
                    <ForeName>Azeem</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0002-2357-9858</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Primary Care and Public Health, Imperial College London, London W6 8RP, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J R Soc Med</MedlineTA>
            <NlmUniqueID>7802879</NlmUniqueID>
            <ISSNLinking>0141-0768</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D022542">Measles-Mumps-Rubella Vaccine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008457" MajorTopicYN="N">Measles</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D022542" MajorTopicYN="N">Measles-Mumps-Rubella Vaccine</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>17</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33175649</ArticleId>
            <ArticleId IdType="doi">10.1177/0141076820972668</ArticleId>
            <ArticleId IdType="pmc">PMC7731639</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2018 Mar 31;391(10127):1285-1300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29248255</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jun 12;368(6496):1163</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32527804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Aug;20(8):464-470</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32461674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Jun 23;369:m2503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32576558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Jul 15;370:m2743</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32669358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2019 Dec 06;68(48):1105-1111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31805033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2019 Nov 1;366(6465):599-606</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31672891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Apr;580(7804):446-447</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32265541</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Public Health. 2020 Oct 1;30(5):847-848</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32745211</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33171100</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>21</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4172</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>183</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>12</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell</Title>
                <ISOAbbreviation>Cell</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1479-1495.e20</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0092-8674(20)31444-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2020.10.037</ELocationID>
            <Abstract>
                <AbstractText>We present an integrated analysis of the clinical measurements, immune cells, and plasma multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial blood draws collected during the first week of infection following diagnosis. We identify a major shift between mild and moderate disease, at which point elevated inflammatory signaling is accompanied by the loss of specific classes of metabolites and metabolic processes. Within this stressed plasma environment at moderate disease, multiple unusual immune cell phenotypes emerge and amplify with increasing disease severity. We condensed over 120,000 immune features into a single axis to capture how different immune cell classes coordinate in response to SARS-CoV-2. This immune-response axis independently aligns with the major plasma composition changes, with clinical metrics of blood clotting, and with the sharp transition between mild and moderate disease. This study suggests that moderate disease may provide the most effective setting for therapeutic intervention.</AbstractText>
                <CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Yapeng</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yuan</LastName>
                    <ForeName>Dan</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lausted</LastName>
                    <ForeName>Christopher</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Jongchan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dai</LastName>
                    <ForeName>Chengzhen L</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Voillet</LastName>
                    <ForeName>Valentin</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, NPC (HCRISA), Cape Town 8001, South Africa; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duvvuri</LastName>
                    <ForeName>Venkata R</ForeName>
                    <Initials>VR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scherler</LastName>
                    <ForeName>Kelsey</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Troisch</LastName>
                    <ForeName>Pamela</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baloni</LastName>
                    <ForeName>Priyanka</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qin</LastName>
                    <ForeName>Guangrong</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Brett</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kornilov</LastName>
                    <ForeName>Sergey A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rostomily</LastName>
                    <ForeName>Clifford</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Alex</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Shen</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rothchild</LastName>
                    <ForeName>Alissa</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Isoplexis Corporation, Branford, CT 06405, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Kim</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Edmark</LastName>
                    <ForeName>Rick</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hong</LastName>
                    <ForeName>Sunga</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heath</LastName>
                    <ForeName>John E</ForeName>
                    <Initials>JE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Earls</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Rongyu</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Jingyi</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roper</LastName>
                    <ForeName>Ryan</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jones</LastName>
                    <ForeName>Lesley</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Yong</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rowen</LastName>
                    <ForeName>Lee</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Rachel</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mackay</LastName>
                    <ForeName>Sean</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Isoplexis Corporation, Branford, CT 06405, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Mahony</LastName>
                    <ForeName>D Shane</ForeName>
                    <Initials>DS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dale</LastName>
                    <ForeName>Christopher R</ForeName>
                    <Initials>CR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wallick</LastName>
                    <ForeName>Julie A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Algren</LastName>
                    <ForeName>Heather A</ForeName>
                    <Initials>HA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zager</LastName>
                    <ForeName>Michael A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Data Visualization, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>ISB-Swedish COVID19 Biobanking Unit</CollectiveName>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Price</LastName>
                    <ForeName>Nathan D</ForeName>
                    <Initials>ND</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Sui</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Subramanian</LastName>
                    <ForeName>Naeha</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Global Heath, and Department of Immunology, University of Washington, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Kai</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Magis</LastName>
                    <ForeName>Andrew T</ForeName>
                    <Initials>AT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hadlock</LastName>
                    <ForeName>Jenn J</ForeName>
                    <Initials>JJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hood</LastName>
                    <ForeName>Leroy</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aderem</LastName>
                    <ForeName>Alan</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bluestone</LastName>
                    <ForeName>Jeffrey A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lanier</LastName>
                    <ForeName>Lewis L</ForeName>
                    <Initials>LL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, University of California, San Francisco, and Parker Institute for Cancer Immunotherapy, San Francisco, CA 94143, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greenberg</LastName>
                    <ForeName>Philip D</ForeName>
                    <Initials>PD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Departments of Immunology and Medicine, University of Washington, Seattle, WA 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gottardo</LastName>
                    <ForeName>Raphael</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Statistics, University of Washington, Seattle, WA 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Davis</LastName>
                    <ForeName>Mark M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; The Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goldman</LastName>
                    <ForeName>Jason D</ForeName>
                    <Initials>JD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA; Division of Allergy &amp; Infectious Diseases, University of Washington, Seattle, WA 98109, USA. Electronic address: jason.goldman@swedish.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heath</LastName>
                    <ForeName>James R</ForeName>
                    <Initials>JR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA. Electronic address: jim.heath@isbscience.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R21 AI138258</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U19 AI057229</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DA040395</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UG3 TR002884</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AI068129</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U19 AI128914</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016430">Clinical Trial</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell</MedlineTA>
            <NlmUniqueID>0413066</NlmUniqueID>
            <ISSNLinking>0092-8674</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000081246" MajorTopicYN="Y">RNA-Seq</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059010" MajorTopicYN="Y">Single-Cell Analysis</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">CITE-seq</Keyword>
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">immune response</Keyword>
            <Keyword MajorTopicYN="Y">infection</Keyword>
            <Keyword MajorTopicYN="Y">metabolomics</Keyword>
            <Keyword MajorTopicYN="Y">multi-omics</Keyword>
            <Keyword MajorTopicYN="Y">proteomics</Keyword>
            <Keyword MajorTopicYN="Y">single-cell RNA-seq</Keyword>
            <Keyword MajorTopicYN="Y">single-cell TCR-seq</Keyword>
            <Keyword MajorTopicYN="Y">single-cell secretome</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Interests J.R.H. is founder and board member of Isoplexis and PACT Pharma. M.M.D. is a member of the Scientific Advisory Board of PACT Pharma. J.A.B. is a member of the Scientific Advisory Boards of Arcus, Celsius, and VIR. J.A.B. is a member of the Board of Directors of Rheos and Provention. J.A.B. has recently joined Sonoma Biotherapeutics as President and CEO. Sonoma Biotherapeutics is involved in developing novel Treg-based cell therapies for the treatment of autoimmune diseases. R.G. has received consulting income from Juno Therapeutics, Takeda, Infotech Soft, Celgene, Merck and has received research support from Janssen Pharmaceuticals and Juno Therapeutics, and declares ownership in CellSpace Biosciences. P.D.G is on the Scientific Advisory Board of Celsius, Earli, Elpiscience, Immunoscape, Rapt, and Nextech, was a scientific founder of Juno Therapeutics, and receives research support from Lonza. J.D.G. declared contracted research with Gilead, Lilly, and Regeneron. The remaining authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>20</Hour>
                <Minute>9</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33171100</ArticleId>
            <ArticleId IdType="pii">S0092-8674(20)31444-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId>
            <ArticleId IdType="pmc">PMC7598382</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2001 Jan 1;166(1):232-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11123297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2018 Dec 03;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30531897</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2016 May;13(3):354-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26996069</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2012 Sep 28;151(1):68-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23021216</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2018 May 15;48(5):1029-1045.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29768164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 May 11;11(1):2345</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32393797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2018 Apr 17;48(4):716-729.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29625895</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2011 Jun;12(6):492-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21739672</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunology. 2002 Jun;106(2):127-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12047742</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1999 Jun 1;162(11):6572-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10352273</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2014 Oct 16;41(4):529-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25367570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunother. 2010 May;33(4):382-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20386468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Rev. 2009 May;229(1):114-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19426218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Commun Signal. 2011 Apr 08;9:7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21477291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2017 Aug 1;199(3):911-919</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28652395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Aug 21;5(50):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32826343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2015 Sep;12(5):558-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25683611</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E607-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25646488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Res Ther. 2005;7(5):R1001-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16207316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1996 May 1;156(9):3111-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8617931</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunology. 1999 May;97(1):159-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10447727</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2018 Feb 6;19(1):15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29409532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5610-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15044705</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2020 Sep 15;36(18):4817-4818</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32614448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2001 Jan 15;166(2):877-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11145663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Oct 1;183(1):143-157.e13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32877699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2019 Oct 17;10(1):4706</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31624246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2018 Nov 28;9:2809</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30546369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Comput Biol. 2019 Jun 5;15(6):e1007034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31166947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2018 Jul 24;24(4):935-946</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30044989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Methods. 2020 Mar;17(3):261-272</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015543</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2018 Jul 26;174(3):716-729.e27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29961576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Apr 3;7(1):524</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28373665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Cell Biol. 2017 Jan;95(1):33-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27465674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2016 Apr 12;7:11273</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27068492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2017 Jan 23;8:19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28167943</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immunol Immunother. 2016 Apr;65(4):441-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26850637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2018 Jul 31;24(5):1105-1112.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30067968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Methods. 2020 Feb;17(2):137-145</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31792435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytometry. 1997 Jan 1;27(1):71-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9000587</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>United European Gastroenterol J. 2020 Jun;8(5):509-519</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32450787</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Sep 4;369(6508):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32669297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2010 Mar;16(3):279-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20190767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JCI Insight. 2020 Jul 23;5(14):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32559180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Jul 8;11(1):3410</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32641700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16199517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Syst. 2019 Apr 24;8(4):281-291.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30954476</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2019 May;196(2):226-236</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30693467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunobiology. 2016 Jan;221(1):31-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26310579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 May;20(5):269-270</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273594</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2020 May;17(5):533-535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32203188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Jul;26(7):1070-1076</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32514174</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2001 Jan 15;166(2):900-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11145666</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2015 Aug;15(8):486-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26205583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anesth Analg. 2020 Sep;131(3):e175-e176</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32541247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 May 01;11:827</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32425950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2004 Sep 1;10(17):5828-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15355913</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EClinicalMedicine. 2020 May 03;23:100375</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32368728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Jul 15;5(49):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32669287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Bioinformatics. 2013 Jan 16;14:7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23323831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2017 May 4;545(7652):60-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28397821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2016 May 17;44(5):989-1004</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27192565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Protoc. 2020 Jul;15(7):2247-2276</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32561888</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Mar 26;9(1):5233</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30914743</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2010 Jun 15;181(12):1407-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20167847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):463-469</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32717743</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Sep 17;182(6):1419-1440.e23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32810438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Sep 17;182(6):1401-1418.e18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32810439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2006 Dec;36(12):3356-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17125142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2017 Mar 23;8:319</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28386257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2017 Jul 3;13(7):1625-1629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28362549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2020 Feb 1;36(3):964-965</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31400197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2006 Feb 1;176(3):1439-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16424171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10324-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20479229</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2012 Nov 30;338(6111):1220-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23197535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Mol Med. 2015 Feb 13;47:e141</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25676064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Sep 4;369(6508):1210-1220</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32788292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2015 Dec 10;16:278</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26653891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Transplant. 2008 Mar;8(3):627-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18294159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Immunol. 2019 Jan;80(1):37-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29715484</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2008 May;9(5):503-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18425107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Discov. 2013 Apr;3(4):418-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23519018</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32320677</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Jul 9;182(1):59-72.e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492406</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2016 May 15;196(10):4064-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27076679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Oct;26(10):1636-1643</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32839624</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 7;369(6504):718-724</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 May 15;174(10):5915-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15879081</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Sci. 2007 Nov 15;120(Pt 22):3999-4008</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17971417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2016 May 16;6:25629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27181049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13235-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25157127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2020 Sep;21(9):1107-1118</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32788748</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33168971</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1476-4687</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>587</Volume>
                    <Issue>7833</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>11</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nature</Title>
                <ISOAbbreviation>Nature</ISOAbbreviation>
            </Journal>
            <ArticleTitle>'I've never worked harder': the race to develop a COVID-19 vaccine.</ArticleTitle>
            <Pagination>
                <MedlinePgn>322</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/d41586-020-03139-x</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Woolston</LastName>
                    <ForeName>Chris</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D062210">Personal Narrative</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nature</MedlineTA>
            <NlmUniqueID>0410462</NlmUniqueID>
            <ISSNLinking>0028-0836</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017326" MajorTopicYN="N">Clinical Trials, Phase III as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012108" MajorTopicYN="N">Research Personnel</DescriptorName>
                <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016526" MajorTopicYN="Y">Workload</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Careers</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Vaccines</Keyword>
            <Keyword MajorTopicYN="Y">Virology</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>5</Hour>
                <Minute>43</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33168971</ArticleId>
            <ArticleId IdType="doi">10.1038/d41586-020-03139-x</ArticleId>
            <ArticleId IdType="pii">10.1038/d41586-020-03139-x</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33167900</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2334</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Nov</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC infectious diseases</Title>
                <ISOAbbreviation>BMC Infect Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>818</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-020-05549-8</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To explore the kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This observational study enrolled 20 patients with COVID-19, who were hospitalized between January 20-April 6, 2020, in the two COVID-19 designated hospitals of Zhoushan, Zhejiang and Rushan, Shandong, China, The laboratory findings, imaging, serum response to viral infection, and viral RNA level in the throat and stool samples were assessed from onset to recovery phase in patients with COVID-19.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">SARS-COV-2 RNA was positive as early as day four. It remained positive until day 55 post-onset in the sputum-throat swabs and became negative in most cases (55%) within 14...days after onset. Lymphocytopenia occurred in 40% (8/20) of patients during the peak infection period and returned to normal at week five. The most severe inflammation in the lungs appeared in week 2 or 3 after onset, and this was completely absorbed between week 6 and 8 in 85.7% of patients. All patients had detectable antibodies to the receptor binding domain (RBD), and 95% of these patients had IgG to viral N proteins. The antibody titer peaked at week four. Anti-S IgM was positive in 7 of 20 patients after week three.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">All COVID-19 patients in this study were self-limiting and recovered well though it may take as long as 6-8...weeks. Our findings on the kinetic changes in imaging, serum response to viral infection and viral RNA level may help understand pathogenesis and define clinical course of COVID-19.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Qiu-Jing</ForeName>
                    <Initials>QJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, NO.739 Dingshen Road, Zhoushan City, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yao</LastName>
                    <ForeName>Yan-Zhen</ForeName>
                    <Initials>YZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory, Zhoushan Hospital, WenZhou Medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Jun-Shuai</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Emergency, Rushan People's Hospital, Shandong, 264500, Rushan, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Qiao</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Li-Yun</ForeName>
                    <Initials>LY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell and Molecular Biology Laboratory, Zhoushan Hospital, Wenzhou medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bao</LastName>
                    <ForeName>Zhou-Jun</ForeName>
                    <Initials>ZJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory, Zhoushan Hospital, WenZhou Medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mao</LastName>
                    <ForeName>Dai-Wen</ForeName>
                    <Initials>DW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, NO.739 Dingshen Road, Zhoushan City, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Ji-Hang</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell and Molecular Biology Laboratory, Zhoushan Hospital, Wenzhou medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Zhe-En</ForeName>
                    <Initials>ZE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, NO.739 Dingshen Road, Zhoushan City, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, NO.739 Dingshen Road, Zhoushan City, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yi-Wei</ForeName>
                    <Initials>YW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Laboratory, Zhoushan Hospital, WenZhou Medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>He-Ping</ForeName>
                    <Initials>HP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology Diagnostic Center, Zhoushan Hospital, WenZhou Medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Lue</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Zhoushan Hospital, WenZhou Medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Hai-Yan</ForeName>
                    <Initials>HY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Zhoushan Hospital, WenZhou Medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Guo-Qiang</ForeName>
                    <Initials>GQ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastrointestinal Surgery, Zhoushan Hospital, WenZhou Medical University, Zhoushan, 316021, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Shi-Bo</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, NO.739 Dingshen Road, Zhoushan City, 316021, Zhejiang, China. lsb0398@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2020C31001</GrantID>
                    <Agency>New Coronavirus Pneumonia Prevention and Control Technology Project of Zhoushan, Zhejiang province</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2020C31002</GrantID>
                    <Agency>New Coronavirus Pneumonia Prevention and Control Technology Project of Zhoushan, Zhejiang province</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2020C03123</GrantID>
                    <Agency>Emergency research project of Zhejiang Province's key R&amp;D plan</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D064888">Observational Study</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Infect Dis</MedlineTA>
            <NlmUniqueID>100968551</NlmUniqueID>
            <ISSNLinking>1471-2334</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086462">Coronavirus Nucleocapsid Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000706170">Covid-19 aAPC vaccine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000705834">nucleocapsid phosphoprotein, SARS-CoV-2</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019411" MajorTopicYN="Y">Clinical Laboratory Techniques</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086462" MajorTopicYN="N">Coronavirus Nucleocapsid Proteins</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013183" MajorTopicYN="N">Sputum</DescriptorName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antibody response and qRT-PCR</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Lung image</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>5</Hour>
                <Minute>31</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33167900</ArticleId>
            <ArticleId IdType="doi">10.1186/s12879-020-05549-8</ArticleId>
            <ArticleId IdType="pii">10.1186/s12879-020-05549-8</ArticleId>
            <ArticleId IdType="pmc">PMC7652587</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Gastroenterol Hepatol. 2020 Apr;5(4):335-337</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32087098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12781535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2009 Jul;83(14):7221-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19420077</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Feb 19;368:m606</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32075786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2020 Apr;46(4):586-590</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32125455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 23;382(17):1663-1665</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32187458</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2007 Sep 13;357(11):1162-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17855683</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Mar 28;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1999 Oct 6;282(13):1240-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10517426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2003 Mar;77(5):2922-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12584316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Microbes Infect. 2020 Dec;9(1):382-385</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32065055</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):514-523</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Rev. 2015 Apr;28(2):465-522</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25810418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Mar 26;368:m1091</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Struct Biol. 2011 Apr;174(1):11-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21130884</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1990 Nov;64(11):5367-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2170676</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2017 Jul;23(7):1079-1084</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28585916</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 May;20(5):565-574</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32213337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2020 Aug;296(2):E55-E64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32191587</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007143</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33167401</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">2076-0817</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>9</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Nov</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pathogens (Basel, Switzerland)</Title>
                <ISOAbbreviation>Pathogens</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antibody-Based Immunotherapeutic Strategies for COVID-19.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E917</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens9110917</ELocationID>
            <Abstract>
                <AbstractText>Global efforts to contain the coronavirus disease-2019 (COVID-19) include the development of novel preventive vaccines and effective therapeutics. Passive antibody therapies using convalescent plasma, SARS-CoV-2 (Severe-Acute-Respiratory-Syndrome-Corona-Virus-2)-specific neutralizing antibodies (NAbs), and the development of monoclonal antibodies (MAbs) are among the most promising strategies for prophylaxis and treatment of SARS-CoV-2 infections. In addition, several immunomodulatory antibodies acting via several mechanisms to boost the host immune defense against SARS-CoV-2 infection as well as to avoid the harmful overreaction of the immune system are currently under clinical trial. Our main objective is to present the current most up-to-date progress in some clinical trials registered at ClinicalTrials.gov. We highlight the pros and pitfalls of several SARS-CoV-2 antibody-based immunotherapeutics.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hussen</LastName>
                    <ForeName>Jamal</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">0000-0001-8942-005X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kandeel</LastName>
                    <ForeName>Mahmoud</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0003-3668-5147</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Hofuf, Al-Ahsa 31982, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh 33516, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hemida</LastName>
                    <ForeName>Maged Gomaa</ForeName>
                    <Initials>MG</Initials>
                    <Identifier Source="ORCID">0000-0002-5986-7237</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh 33516, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Mubarak</LastName>
                    <ForeName>Abdullah I A</ForeName>
                    <Initials>AIA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>11-BIO1823-06</GrantID>
                    <Agency>King Abdulaziz City for Science and Technology</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Pathogens</MedlineTA>
            <NlmUniqueID>101596317</NlmUniqueID>
            <ISSNLinking>2076-0817</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS CoV-2</Keyword>
            <Keyword MajorTopicYN="N">antibodies</Keyword>
            <Keyword MajorTopicYN="N">clinical trials</Keyword>
            <Keyword MajorTopicYN="N">immunotherapy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>1</Hour>
                <Minute>5</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33167401</ArticleId>
            <ArticleId IdType="pii">pathogens9110917</ArticleId>
            <ArticleId IdType="doi">10.3390/pathogens9110917</ArticleId>
            <ArticleId IdType="pmc">PMC7694378</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Arthritis Rheumatol. 2020 Jul;72(7):1059-1063</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32293098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Immunol. 2020 Nov;40(8):1082-1092</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32829467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jul;20(7):401-403</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32533109</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2020 Jun;46(6):1294-1297</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32253449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Joint Bone Spine. 2020 May;87(3):191-193</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32321634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Rep. 2020 Oct;47(10):8229-8233</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32920757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Signal Transduct Target Ther. 2020 Sep 15;5(1):203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32934211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Nov 19;71(16):2027-2034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Sci. 2020 Apr 6;16(11):1846-1860</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32398954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 May 1;130(5):2620-2629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jun;20(6):345-346</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32358580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2020 Aug;17(8):887-888</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32382131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2019 Sep 04;10:2055</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31552022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Pathol. 2020 Oct 13;154(5):610-619</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32808976</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood Cells Mol Dis. 2020 Jul;83:102424</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32208292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EBioMedicine. 2020 Jul;57:102836</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32574958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol Sin. 2020 Jun;35(3):266-271</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32125642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Apr;26(4):453-455</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32284614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Sci. 2020 Jun 04;10(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32512702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomed Sci. 2020 Jan 2;27(1):1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31894001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Sep 8;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32897544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Adv Res. 2020 Mar 16;24:91-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32257431</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2020 Jul 21;21(14):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32708334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1237-L1238</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32464083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jul 29;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32726800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Rheumatol. 2020 Aug;2(8):e457-ee458</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835251</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 2020 Sep 11;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32919977</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>F1000Res. 2020 Jan 31;9:72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32117569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Mol Biosci. 2020 Jul 03;7:157</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32719810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2020 Sep 16;:1-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32936732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Jun;127:104380</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32353761</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Chem Neurosci. 2020 Jun 3;11(11):1555-1562</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32379417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Sep 12;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32918755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jun;20(6):343-344</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32327719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Clin Cases. 2020 Sep 6;8(17):3763-3773</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32953852</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Rheumatol. 2020 Nov;2(11):e659-e660</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32838327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 14;324(2):131-132</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32539093</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Sci. 2020 Mar 15;16(10):1718-1723</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32226289</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformation. 2020 Mar 31;16(3):219-222</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32308263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Cardiovasc Med. 2020 Jul 14;7:140</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32760740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>IUBMB Life. 2020 Sep 16;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32936531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respirology. 2020 Sep 20;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32954552</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Sep 16;:1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32936048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Nov 27;370(6520):1110-1115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33037066</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Immunopharmacol. 2020 Jun;83:106455</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32272396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>An Pediatr (Barc). 2020 Jul;93(1):60.e1-60.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32439309</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Jun 09;11:1137</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32582207</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Nanotechnol. 2020 Aug;15(8):630-645</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661375</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Res Clin Pract. 2020 Jul;165:108280</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32592839</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cardiol. 2020 Aug 24;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32830894</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Nov 20;370(6519):950-957</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32972994</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 Apr 1;130(4):1545-1548</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32167489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Travel Med Infect Dis. 2020 Sep - Oct;37:101755</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32479816</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Immunopharmacol. 2020 Jul;84:106519</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32311668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2020 Sep;286:198043</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32502551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Drug Discov. 2020 Sep;7:100056</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 May;20(5):269-270</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273594</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Rheumatol. 2020 Jul;39(7):2085-2094</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32474885</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2020 Jul;75(7):1564-1581</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32396996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2013 Mar;20(3):319-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23283640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2020 May;17(5):533-535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32203188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Jun 16;11:1441</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32612615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Elife. 2020 Jul 29;9:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32723480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Am Thorac Soc. 2020 Sep;17(9):1164-1168</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32579033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2020 Jul 06;21(13):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32640747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Aug;97:236-239</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32565366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32064853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JACC Basic Transl Sci. 2020 Sep;5(9):871-883</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32838074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32253318</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Mar 27;367(6485):1444-1448</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32132184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):692-694</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 May;20(5):565-574</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32213337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccines (Basel). 2020 May 14;8(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32423059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Jun;55(6):105982</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32305588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Hypotheses. 2020 Jul;140:109749</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32339777</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stem Cell Rev Rep. 2020 Jun;16(3):434-440</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32307653</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Mar 27;11(1):1620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Braz J Infect Dis. 2020 Sep - Oct;24(5):428-433</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32866437</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Aug 5;:1-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32752936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2003 Dec;28(3):245-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14522062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32192578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Aug;81(2):e136-e138</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32504739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Aug;20(8):507-514</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32576980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32142651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EBioMedicine. 2020 Oct;60:102999</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32950003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Surg. 2020 Aug 10;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32776522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Rheumatol. 2020 Aug;2(8):e465-e473</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Apr;92(4):424-432</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31981224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Jul 03;11:1625</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32719685</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32105090</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32105632</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunotargets Ther. 2020 Jun 11;9:111-114</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32607314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Med Virol. 2020 Sep;30(5):e2123</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32648313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Influenza Other Respir Viruses. 2020 Jul;14(4):472-473</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32223072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BioDrugs. 2020 Jun;34(3):273-293</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32157600</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33166303</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1545-7885</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>18</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>11</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PLoS biology</Title>
                <ISOAbbreviation>PLoS Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Monitor for COVID-19 vaccine resistance evolution during clinical trials.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e3001000</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pbio.3001000</ELocationID>
            <Abstract>
                <AbstractText>Although less common than the evolution of antimicrobial drug resistance, vaccine resistance can and has evolved. How likely is it that COVID-19 vaccines currently in development will be undermined by viral evolution? We argue that this can be determined by repurposing samples that are already being collected as part of clinical trials. Such information would be useful for prioritizing investment among candidate vaccines and maximizing the potential long-term impact of COVID-19 vaccines.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kennedy</LastName>
                    <ForeName>David A</ForeName>
                    <Initials>DA</Initials>
                    <Identifier Source="ORCID">0000-0003-0820-115X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Center for Infectious Disease Dynamics, Department of Biology, The Pennsylvania State University, Pennsylvania, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Read</LastName>
                    <ForeName>Andrew F</ForeName>
                    <Initials>AF</Initials>
                    <Identifier Source="ORCID">0000-0001-7604-7903</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Center for Infectious Disease Dynamics, Department of Biology, The Pennsylvania State University, Pennsylvania, United States of America.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Entomology, The Pennsylvania State University, Pennsylvania, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS Biol</MedlineTA>
            <NlmUniqueID>101183755</NlmUniqueID>
            <ISSNLinking>1544-9173</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>17</Hour>
                <Minute>12</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33166303</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pbio.3001000</ArticleId>
            <ArticleId IdType="pii">PBIOLOGY-D-20-03034</ArticleId>
            <ArticleId IdType="pmc">PMC7676675</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12878-12886</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30559199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Biol Sci. 2017 Mar 29;284(1851):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28356449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 21;369(6506):1014-1018</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32540904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 21;369(6506):956-963</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32540903</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6571-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9177259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2009 Sep 25;325(5948):1705-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19696313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):516-527</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32967006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Evol. 2011 Jan;28(1):707-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20833694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Biol. 2015 Jul 27;13(7):e1002198</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26214839</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2002 Mar 15;185(6):820-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11920300</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2019 Apr 26;10:655</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31105686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2011 Dec 3;378(9807):1962-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21492929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2010 Aug 2;28(34):5513-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20600514</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33165503</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1537-6591</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Nov</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title>
                <ISOAbbreviation>Clin Infect Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">ciaa1703</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciaa1703</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We evaluated an inactivated SARS-CoV-2 vaccine for immunogenicity and safety in adults aged 18-59 years.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In this randomized, double-blinded and controlled trial, healthy adults received a medium (MD) or a high dose (HD) of the vaccine at an interval of either 14 days or 28 days. Neutralizing antibody (NAb) and anti-S and anti-N antibodies were detected at different times, and adverse reactions were monitored for 28 days after full immunization.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 742 adults were enrolled in the immunogenicity and safety analysis. Among subjects in the 0, 14 procedure, the seroconversion rates of NAb in MD and HD groups were 89% and 96% with GMTs of 23 and 30, respectively, at day 14 and 92% and 96% with GMTs of 19 and 21, respectively at day 28 after immunization. Anti-S antibodies had GMTs of 1883 and 2370 in MD and 2295 and 2432 in HD group. Anti-N antibodies had GMTs of 387 and 434 in MD group and 342 and 380 in HD group. Among subjects in the 0, 28 procedure, seroconversion rates for NAb at both doses were both 95% with GMTs of 19 at day 28 after immunization. Anti-S antibodies had GMTs of 937 and 929 for MD and HD group, and anti-N antibodies had GMTs of 570 and 494 for MD and HD group, respectively. No serious adverse events were observed during the study period.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Adults vaccinated with inactivated SARS-CoV-2 vaccine had NAb as well as anti-S/N antibody, and had a low rate of adverse reactions.</AbstractText>
                <AbstractText Label="CLINICAL TRIALS REGISTRATION" NlmCategory="BACKGROUND">NCT04412538.</AbstractText>
                <CopyrightInformation>.. The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Che</LastName>
                    <ForeName>Yanchun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xiaoqiang</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yunnan Center for Disease Control and Prevention, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pu</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gejiu Center for Disease Control and Prevention, Gejiu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Meijian</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Mile Center for Disease Control and Prevention, Mile, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Zhimei</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Ruiju</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yin</LastName>
                    <ForeName>Zhifang</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute of Food and Drug Control, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Mingjue</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yin</LastName>
                    <ForeName>Qiongzhou</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jianfeng</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute of Food and Drug Control, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pu</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Heng</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Lichun</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Ya</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Mile Center for Disease Control and Prevention, Mile, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lei</LastName>
                    <ForeName>Jin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gejiu Center for Disease Control and Prevention, Gejiu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yunnan Center for Disease Control and Prevention, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liao</LastName>
                    <ForeName>Yun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Long</LastName>
                    <ForeName>Runxiang</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cui</LastName>
                    <ForeName>Pingfang</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Huijuan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yuehui</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gejiu Center for Disease Control and Prevention, Gejiu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jingyu</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yunnan Center for Disease Control and Prevention, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Weiwu</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Mile Center for Disease Control and Prevention, Mile, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Zhanlong</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Kaili</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hong</LastName>
                    <ForeName>Chao</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Dandan</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Guorun</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Donglan</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Xingli</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fan</LastName>
                    <ForeName>Shengtao</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheng</LastName>
                    <ForeName>Chen</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Hongling</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Jianbo</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zou</LastName>
                    <ForeName>Yanxiang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Yunnan Center for Disease Control and Prevention, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Youshuai</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Mile Center for Disease Control and Prevention, Mile, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Yaling</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gejiu Center for Disease Control and Prevention, Gejiu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guo</LastName>
                    <ForeName>Yingqiu</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Ting</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Hongbo</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Zhongping</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Changgui</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute of Food and Drug Control, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Qihan</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Biology, Chinese Academy of Medicine Science &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT04412538</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Clin Infect Dis</MedlineTA>
            <NlmUniqueID>9203213</NlmUniqueID>
            <ISSNLinking>1058-4838</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Inactivated SARS-CoV-2 vaccine</Keyword>
            <Keyword MajorTopicYN="N">immunogenicity</Keyword>
            <Keyword MajorTopicYN="N">phase II trial</Keyword>
            <Keyword MajorTopicYN="N">safety</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>14</Hour>
                <Minute>25</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33165503</ArticleId>
            <ArticleId IdType="pii">5962856</ArticleId>
            <ArticleId IdType="doi">10.1093/cid/ciaa1703</ArticleId>
            <ArticleId IdType="pmc">PMC7717222</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33163683</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">2405-8440</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>6</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Heliyon</Title>
                <ISOAbbreviation>Heliyon</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e05421</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2020.e05421</ELocationID>
            <Abstract>
                <AbstractText>Corona virus disease 2019 (COVID-19) is a respiratory disease caused by a new coronavirus (SARS-CoV-2) which causes significant morbidity and mortality. The emergence of this novel and highly pathogenic SARS-CoV-2 and its rapid international spread poses a serious global public health emergency. To date 32,174,627 cases, of which 962,613 (2.99%) have died, have been reported (https://www.who.int/westernpacific/health-topics/coronavirus, accessed 23 Sep 2020). The outbreak was declared a Public Health Emergency of International Concern on 30 January 2020. There are still not many SARS-CoV-2-specific and effective treatments or vaccines available. A second round of infection is obviously unavoidable. Aptamers had already been at the centre of interest in the fight against viruses before now. The selection and development of a new aptamer is, however, a time-consuming process. We therefore checked whether a clinically developed aptamer, BC 007, which is currently in phase 2 of clinical testing for a different indication, would also be able to efficiently bind DNA-susceptible peptide structures from SARS-CoV-2-spreading crucial proteins, such as the receptor binding domain (RBD) of the spike protein and the RNA dependent RNA polymerase of SARS-CoV-2 (re-purposing). Indeed, several such sequence-sections have been identified. In particular for two of these sequences, BC 007 showed specific binding in a therapy-relevant concentration range, as shown in Nuclear magnetic resonance (NMR)- and Circular dicroism (CD)-spectroscopy and isothermal titration calorimetry (ITC). The excellent clinical toxicity and tolerability profile of this substance opens up an opportunity for rapid clinical testing of its COVID-19 effectiveness.</AbstractText>
                <CopyrightInformation>.. 2020 The Author(s).</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Weisshoff</LastName>
                    <ForeName>Hardy</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, NMR Facility, Humboldt University of Berlin, Brook-Taylor-Stra..e 2, 12489 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krylova</LastName>
                    <ForeName>Oxana</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Leibniz-Forschungsinstitut f..r Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Robert-R..ssle-Str. 10, 13125 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nikolenko</LastName>
                    <ForeName>Heike</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Leibniz-Forschungsinstitut f..r Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Robert-R..ssle-Str. 10, 13125 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>D..ngen</LastName>
                    <ForeName>Hans-Dirk</ForeName>
                    <Initials>HD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charit..-Universit..tsmedizin, Augustenburger Platz 1, 13353 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dallmann</LastName>
                    <ForeName>Andre</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, NMR Facility, Humboldt University of Berlin, Brook-Taylor-Stra..e 2, 12489 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Becker</LastName>
                    <ForeName>Susanne</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Berlin Cures GmbH, Knesebeckstr. 59-61, 10719 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>G..ttel</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Berlin Cures GmbH, Knesebeckstr. 59-61, 10719 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>M..ller</LastName>
                    <ForeName>Johannes</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Berlin Cures GmbH, Knesebeckstr. 59-61, 10719 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haberland</LastName>
                    <ForeName>Annekathrin</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Berlin Cures GmbH, Robert-R..ssle-Str. 10, 13125 Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Heliyon</MedlineTA>
            <NlmUniqueID>101672560</NlmUniqueID>
            <ISSNLinking>2405-8440</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antiviral</Keyword>
            <Keyword MajorTopicYN="N">Aptamer</Keyword>
            <Keyword MajorTopicYN="N">BC 007</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Clinical research</Keyword>
            <Keyword MajorTopicYN="N">Health sciences</Keyword>
            <Keyword MajorTopicYN="N">Infectious disease</Keyword>
            <Keyword MajorTopicYN="N">Pharmaceutical science</Keyword>
            <Keyword MajorTopicYN="N">Pharmacology</Keyword>
            <Keyword MajorTopicYN="N">Re-purposing</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        </KeywordList>
        <CoiStatement>S. Becker, P. G..ttel, A. Haberland, J. M..ller are employed by Berlin Cures. P. G..ttel, A. Haberland, J. M..ller are shareholders of Berlin Cures AG. H. Weisshoff is employed by a co-operation project between the Humboldt-Innovation GmbH and Berlin Cures GmbH. A patent had been filed at the European Patent Office (no. 20 168 929.6) by the Berlin Cures GmbH.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>5</Hour>
                <Minute>34</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33163683</ArticleId>
            <ArticleId IdType="doi">10.1016/j.heliyon.2020.e05421</ArticleId>
            <ArticleId IdType="pii">S2405-8440(20)32264-7</ArticleId>
            <ArticleId IdType="pmc">PMC7605794</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>J Med Microbiol. 2020 Jun;69(6):864-873</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32469301</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell. 2020 May 21;78(4):779-784.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32362314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 May 4;11(1):2251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32366817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32155444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Heliyon. 2020 Aug 06;6(8):e04639</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32802980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Heliyon. 2020 Sep;6(9):e05007</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32984620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3745-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8475124</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Sci. 2020 Mar 15;16(10):1718-1723</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32226289</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2003 Jul 1;31(13):3784-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12824418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Immunopathol. 2014 May;36(3):351-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24777744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2004 Nov 12;279(46):48410-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15358767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Pharm Sin B. 2020 May;10(5):766-788</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32292689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chembiochem. 2008 Dec 15;9(18):3037-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19031435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 2016 Oct 15;789:37-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27375076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1992 Feb 6;355(6360):564-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1741036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmaceuticals (Basel). 2016 Dec 16;9(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27999271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2008 Feb 15;366(3):738-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18082623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Transl Sci. 2020 Sep;13(5):896-906</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32589775</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 15;368(6492):779-782</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32277040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Microbiol. 2019 Jul 03;10:1462</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31333603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Crystallogr D Biol Crystallogr. 1996 Mar 1;52(Pt 2):272-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15299700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circ Heart Fail. 2020 Jan;13(1):e006155</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31957469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jun 26;368(6498):1499-1504</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32358203</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Apr 4;395(10230):1101-1102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32247384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Drug Investig. 2020 May;40(5):433-447</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32222912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2020 Nov;85:104497</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32791240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2017 Apr 10;8:15092</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28393837</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 1994 Feb 4;235(5):1532-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8107090</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biomol Struct Dyn. 2020 Oct 4;:1-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33016237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2018 Aug 13;14(8):e1007236</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30102747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Comput Struct Biotechnol J. 2020 Mar 30;18:784-790</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32280433</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2020 Apr;38(4):379-381</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32205870</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharm Sci. 2018 Aug;107(8):2033-2041</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29678593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Angew Chem Int Ed Engl. 2002 Aug 2;41(15):2644-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12203463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2012 Sep;40(16):8119-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22669903</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33163467</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2296-2360</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in pediatrics</Title>
                <ISOAbbreviation>Front Pediatr</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Pediatric Strategy for the Next Phase of the SARS-CoV-2 Pandemic.</ArticleTitle>
            <Pagination>
                <MedlinePgn>582798</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2020.582798</ELocationID>
            <Abstract>
                <AbstractText>Although the first wave of the SARS-CoV-2 pandemic relatively spared children, the next winter season will put a strain on health systems including pediatric services. Clinical staff managing children will need to deal not only with suspected cases of COVID-19, but also with the classic infectious agents that involve children during cold seasons. It will be necessary for physicians, institutions, policy makers, and families to prepare themselves for difficulties of this phase of the pandemic. Otherwise, the same problems experienced during the first wave of SARS-CoV-2, including shortages of human resources, personal protective equipment, and uncertainty, will be exacerbated by significant issues in hospital capacity. Here we highlight the potential role of improved vaccination services, school reorganization, home-outpatient-inpatients flows and telemedicine services in order to face the coming winter season.</AbstractText>
                <CopyrightInformation>Copyright .. 2020 Buonsenso, Valentini, Moscato, Ricciardi and Roland.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Buonsenso</LastName>
                    <ForeName>Danilo</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Global Health Research and Studies, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Valentini</LastName>
                    <ForeName>Piero</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Istituto di Pediatria, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moscato</LastName>
                    <ForeName>Umberto</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Global Health Research and Studies, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ricciardi</LastName>
                    <ForeName>Walter</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Global Health Research and Studies, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sezione di Igiene, Istituto di Sanit.. Pubblica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roland</LastName>
                    <ForeName>Damian</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>SAPPHIRE Group, Health Sciences, Leicester University, Leicester, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Paediatric Emergency Medicine Leicester Academic Group, Children's Emergency Department, Leicester Royal Infirmary, Leicester, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Pediatr</MedlineTA>
            <NlmUniqueID>101615492</NlmUniqueID>
            <ISSNLinking>2296-2360</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">children</Keyword>
            <Keyword MajorTopicYN="N">policy</Keyword>
            <Keyword MajorTopicYN="N">vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>5</Hour>
                <Minute>33</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33163467</ArticleId>
            <ArticleId IdType="doi">10.3389/fped.2020.582798</ArticleId>
            <ArticleId IdType="pmc">PMC7581723</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 9;383(2):187-190</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32356945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Jun;20(6):633-634</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32220651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Infect Dis J. 2020 Aug;39(8):e202-e204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32496407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Infect Dis J. 2020 Jul;39(7):e137-e140</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32404790</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):699-704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32525856</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jun 03;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 21;324(3):259-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32511692</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 2020 Jun 2;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32487724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Emerg Med. 2020 May 15;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32419713</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Rev. 2010 Jan;23(1):74-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20065326</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33163330</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2210-6715</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>65</Volume>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>Feb</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Sustainable cities and society</Title>
                <ISOAbbreviation>Sustain Cities Soc</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A deep learning-based social distance monitoring framework for COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>102571</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scs.2020.102571</ELocationID>
            <Abstract>
                <AbstractText>The ongoing COVID-19 corona virus outbreak has caused a global disaster with its deadly spreading. Due to the absence of effective remedial agents and the shortage of immunizations against the virus, population vulnerability increases. In the current situation, as there are no vaccines available; therefore, social distancing is thought to be an adequate precaution (norm) against the spread of the pandemic virus. The risks of virus spread can be minimized by avoiding physical contact among people. The purpose of this work is, therefore, to provide a deep learning platform for social distance tracking using an overhead perspective. The framework uses the YOLOv3 object recognition paradigm to identify humans in video sequences. The transfer learning methodology is also implemented to increase the accuracy of the model. In this way, the detection algorithm uses a pre-trained algorithm that is connected to an extra trained layer using an overhead human data set. The detection model identifies peoples using detected bounding box information. Using the Euclidean distance, the detected bounding box centroid's pairwise distances of people are determined. To estimate social distance violations between people, we used an approximation of physical distance to pixel and set a threshold. A violation threshold is established to evaluate whether or not the distance value breaches the minimum social distance threshold. In addition, a tracking algorithm is used to detect individuals in video sequences such that the person who violates/crosses the social distance threshold is also being tracked. Experiments are carried out on different video sequences to test the efficiency of the model. Findings indicate that the developed framework successfully distinguishes individuals who walk too near and breaches/violates social distances; also, the transfer learning approach boosts the overall efficiency of the model. The accuracy of 92% and 98% achieved by the detection model without and with transfer learning, respectively. The tracking accuracy of the model is 95%.</AbstractText>
                <CopyrightInformation>.. 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ahmed</LastName>
                    <ForeName>Imran</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Excellence in Information Technology, Institute of Management Sciences, 1-A, Sector E-5, Phase VII, Hayatabad, Peshawar, Pakistan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ahmad</LastName>
                    <ForeName>Misbah</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Excellence in Information Technology, Institute of Management Sciences, 1-A, Sector E-5, Phase VII, Hayatabad, Peshawar, Pakistan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodrigues</LastName>
                    <ForeName>Joel J P C</ForeName>
                    <Initials>JJPC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Post-Graduation Program in Electrical Engineering (PPGEE), Federal University of Piau.., Teresina 64049-550, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Instituto de Telecomunica....es, 1049-001 Lisbon, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeon</LastName>
                    <ForeName>Gwanggil</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Electronic Engineering, Xidian University, Xi'an, 710071, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Embedded Systems Engineering, Incheon National University, Incheon, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Din</LastName>
                    <ForeName>Sadia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Information and Communication Engineering, Yeungnam University, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Sustain Cities Soc</MedlineTA>
            <NlmUniqueID>101735304</NlmUniqueID>
            <ISSNLinking>2210-6707</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Deep learning</Keyword>
            <Keyword MajorTopicYN="N">Overhead view</Keyword>
            <Keyword MajorTopicYN="N">Person detection</Keyword>
            <Keyword MajorTopicYN="N">Social distancing</Keyword>
            <Keyword MajorTopicYN="N">Transfer learning</Keyword>
            <Keyword MajorTopicYN="N">YOLOv3</Keyword>
        </KeywordList>
        <CoiStatement>The authors report no declarations of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>5</Hour>
                <Minute>32</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33163330</ArticleId>
            <ArticleId IdType="doi">10.1016/j.scs.2020.102571</ArticleId>
            <ArticleId IdType="pii">S2210-6707(20)30789-7</ArticleId>
            <ArticleId IdType="pmc">PMC7603992</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2005 Sep 8;437(7056):209-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16079797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2020 Oct 29;15(10):e0240963</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33119629</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33163000</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>07</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1664-3224</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in immunology</Title>
                <ISOAbbreviation>Front Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>585354</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2020.585354</ELocationID>
            <Abstract>
                <AbstractText>A novel coronavirus, which has been designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and causes the highly infectious disease referred to as COVID-19. COVID-19 has now spread worldwide to become a global pandemic affecting over 24 million people as of August 26th, 2020 and claimed the life of more than 800,000 people worldwide. COVID-19 is asymptomatic for some individuals and for others it can cause symptoms ranging from flu-like to acute respiratory distress syndrome (ARDS), pneumonia and death. Although it is anticipated that an effective vaccine will be available to protect against COVID-19, at present the world is relying on social distancing and hygiene measures and repurposed drugs. There is a worldwide effort to develop an effective vaccine against SARS-CoV-2 and, as of late August 2020, there are 30 vaccines in clinical trials with over 200 in various stages of development. This review will focus on the eight vaccine candidates that entered Phase 1 clinical trials in mid-May, including AstraZeneca/Oxford's AZD1222, Moderna's mRNA-1273 and Sinovac's CoronaVac vaccines, which are currently in advanced stages of vaccine development. In addition to reviewing the different stages of vaccine development, vaccine platforms and vaccine candidates, this review also discusses the biological and immunological basis required of a SARS-CoV-2 vaccine, the importance of a collaborative international effort, the ethical implications of vaccine development, the efficacy needed for an immunogenic vaccine, vaccine coverage, the potential limitations and challenges of vaccine development. Although the demand for a vaccine far surpasses the production capacity, it will be beneficial to have a limited number of vaccines available for the more vulnerable population by the end of 2020 and for the rest of the global population by the end of 2021.</AbstractText>
                <CopyrightInformation>Copyright .. 2020 Sharma, Sultan, Ding and Triggle.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sharma</LastName>
                    <ForeName>Omna</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Weill Cornell Medicine-Qatar, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sultan</LastName>
                    <ForeName>Ali A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Medical Education and Pharmacology, Weill Cornell Medicine-Qatar, Education City, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Triggle</LastName>
                    <ForeName>Chris R</ForeName>
                    <Initials>CR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Medical Education and Pharmacology, Weill Cornell Medicine-Qatar, Education City, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Immunol</MedlineTA>
            <NlmUniqueID>101560960</NlmUniqueID>
            <ISSNLinking>1664-3224</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019444">Vaccines, DNA</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071497" MajorTopicYN="N">Immunogenicity, Vaccine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019444" MajorTopicYN="N">Vaccines, DNA</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19 pandemic</Keyword>
            <Keyword MajorTopicYN="Y">DNA vaccine</Keyword>
            <Keyword MajorTopicYN="Y">RNA vaccine</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">inactivated virus particle vaccine</Keyword>
            <Keyword MajorTopicYN="Y">neutralizing antibodies</Keyword>
            <Keyword MajorTopicYN="Y">non-replication viral vector vaccine</Keyword>
            <Keyword MajorTopicYN="Y">vaccine development</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>5</Hour>
                <Minute>31</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33163000</ArticleId>
            <ArticleId IdType="doi">10.3389/fimmu.2020.585354</ArticleId>
            <ArticleId IdType="pmc">PMC7591699</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Ther. 2020 Jul 8;28(7):1548-1549</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32533920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):567-571</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32756549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Apr;26(4):450-452</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32284615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunology. 2020 Jul;160(3):223-232</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32460358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Postgrad Med. 2016 Jan-Mar;62(1):4-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26732191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):945-946</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32385100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 20;182(4):794-795</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32697970</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 21;382(21):1969-1973</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32227757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32075877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):457-462</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32668444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pathogens. 2020 Jun 28;9(7):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32605194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Sep 8;324(10):951-960</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32789505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prog Pediatr Cardiol. 2020 Jun 6;:101254</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32837144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2012 Nov 1;8(11):1694-702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23111168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trials. 2020 Oct 15;21(1):853</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33059771</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 12;383(20):1920-1931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32663912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Jun 25;181(7):1489-1501.e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32473127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 2006 Mar 15;193(6):792-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16479513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jul 3;369(6499):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101623</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32179124</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther. 2020 Jul 8;28(7):1555-1556</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32553431</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Microbiol. 2020 Apr 24;11:658</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32390971</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 Jun 16;52(6):910-941</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32505227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 6;182(3):722-733.e11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32645327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Sep 3;383(10):e63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32610006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2020 May;19(5):305-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32273591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 1;383(14):1296-1299</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32589371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Hemorheol Microcirc. 2020;75(1):13-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32538831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbes Infect. 2020 Mar;22(2):74-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32017984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):479-488</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Aug;20(8):e198-e203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32479747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):334-335</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32782400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2019;15(10):2295-2314</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31589551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2015 Jul 2;205:1-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25997928</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Vaccine Res. 2015 Jan;4(1):46-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25648742</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):948-950</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32393526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Jun 13;395(10240):1845-1854</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32450106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Jun 25;181(7):1458-1463</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Aug 6;182(3):713-721.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32778225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7799):321</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32179860</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jul;583(7818):669-670</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32710003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2020 May 19;52(5):737-741</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32433946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2020 Jun 5;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32641838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Travel Med. 2020 Mar 13;27(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32052846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>mSphere. 2020 May 13;5(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32404514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Ethics. 2020 Aug;46(8):499-501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32532826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2020 May 22;16(5):e1008536</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32442210</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33161277</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-2084</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>53</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>12</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</Title>
                <ISOAbbreviation>Drug Resist Updat</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 update: The race to therapeutic development.</ArticleTitle>
            <Pagination>
                <MedlinePgn>100733</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1368-7646(20)30063-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drup.2020.100733</ELocationID>
            <Abstract>
                <AbstractText>The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents an unprecedented challenge to global public health. At the time of this review, COVID-19 has been diagnosed in over 40 million cases and associated with 1.1 million deaths worldwide. Current management strategies for COVID-19 are largely supportive, and while there are more than 2000 interventional clinical trials registered with the U.S. National Library of Medicine (clinicaltrials.gov), results that can clarify benefits and risks of candidate therapies are only gradually becoming available. We herein describe recent advances in understanding SARS-CoV-2 pathobiology and potential therapeutic targets that are involved in viral entry into host cells, viral spread in the body, and the subsequent COVID-19 progression. We highlight two major lines of therapeutic strategies for COVID-19 treatment: 1) repurposing the existing drugs for use in COVID-19 patients, such as antiviral medications (e.g., remdesivir) and immunomodulators (e.g., dexamethasone) which were previously approved for other disease conditions, and 2) novel biological products that are designed to target specific molecules that are involved in SARS-CoV-2 viral entry, including neutralizing antibodies against the spike protein of SARS-CoV-2, such as REGN-COV2 (an antibody cocktail), as well as recombinant human soluble ACE2 protein to counteract SARS-CoV-2 binding to the transmembrane ACE2 receptor in target cells. Finally, we discuss potential drug resistance mechanisms and provide thoughts regarding clinical trial design to address the diversity in COVID-19 clinical manifestation. Of note, preventive vaccines, cell and gene therapies are not within the scope of the current review.</AbstractText>
                <CopyrightInformation>Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Twomey</LastName>
                    <ForeName>Julianne D</ForeName>
                    <Initials>JD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luo</LastName>
                    <ForeName>Shen</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dean</LastName>
                    <ForeName>Alexis Q</ForeName>
                    <Initials>AQ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bozza</LastName>
                    <ForeName>William P</ForeName>
                    <Initials>WP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nalli</LastName>
                    <ForeName>Ancy</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Baolin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States. Electronic address: Baolin.zhang@fda.hhs.gov.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Scotland</Country>
            <MedlineTA>Drug Resist Updat</MedlineTA>
            <NlmUniqueID>9815369</NlmUniqueID>
            <ISSNLinking>1368-7646</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
                <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">ACE2</Keyword>
            <Keyword MajorTopicYN="Y">Antivirals</Keyword>
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">Drug development</Keyword>
            <Keyword MajorTopicYN="Y">Existing drugs</Keyword>
            <Keyword MajorTopicYN="Y">Immunomodulators</Keyword>
            <Keyword MajorTopicYN="Y">Monoclonal antibodies</Keyword>
            <Keyword MajorTopicYN="Y">Repurposed use</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Spike protein</Keyword>
            <Keyword MajorTopicYN="Y">Therapeutic targets</Keyword>
            <Keyword MajorTopicYN="Y">Virus life cycle</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>20</Hour>
                <Minute>31</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33161277</ArticleId>
            <ArticleId IdType="pii">S1368-7646(20)30063-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.drup.2020.100733</ArticleId>
            <ArticleId IdType="pmc">PMC7584885</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Trials. 2020 Jun 3;21(1):468</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32493441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 2020 May 1;432(10):3309-3325</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32320687</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2005 Jul 7;436(7047):112-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16001071</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32183941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 21;369(6506):1010-1014</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32540901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2014 Sep;109:97-109</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24995382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Genet Evol. 2020 Sep;83:104351</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32387564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Pharm Sin B. 2020 May;10(5):766-788</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32292689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2020 Jun;178:104786</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32251767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32187464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Sep 15;324(11):1048-1057</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32821939</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2020 Jul;179:104811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32360182</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2018 Jun 21;51(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29903860</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Oct 5;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33031764</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol Sin. 2020 Jun;35(3):266-271</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32125642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32020029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 May 4;11(1):2251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32366817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2020 Aug;30(8):678-692</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32541865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32150618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2017 Jun 28;9(396):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28659436</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Open Forum Infect Dis. 2020 Jun 19;7(8):ofaa236</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32766380</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2019 Sep;169:104541</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31233808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Arthritis Rheum. 1993 Oct;23(2 Suppl 1):82-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8278823</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Pharmacol. 2010 Aug;78(2):319-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20466822</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Resist Updat. 2020 Dec;53:100721</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33132205</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Immunol. 2020 May;41(5):355-359</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32249063</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Resist Updat. 2020 Dec;53:100719</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32717568</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32194981</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 May 28;181(5):1004-1015.e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32375025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 May 8;5(47):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32385052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2017 Sep 7;21(1):234</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28877748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Struct Mol Biol. 2020 Sep;27(9):846-854</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32661423</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2020 May;97(5):829-838</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32247631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Rheumatol. 2020 Aug;2(8):e474-e484</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32835257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Sci. 2020 Mar 15;16(10):1718-1723</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32226289</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7819):115-119</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32454513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2020 Mar;19(3):149-150</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32127666</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>mBio. 2018 Mar 6;9(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29511076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 2;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33264556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 7;369(6504):706-712</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32527925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 19;383(21):2030-2040</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33031652</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2003 Sep;84(Pt 9):2305-2315</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12917450</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 Jun 10;27(6):870-878</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32464097</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2020 Jun;17(6):613-620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32203189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virol J. 2005 Aug 22;2:69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16115318</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Sep 3;383(10):992-993</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32649075</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2020 May 4;217(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32289152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Jan 10;11(1):222</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31924756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2020 Apr;176:104742</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32057769</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ther Deliv. 2020 Apr;11(4):245-268</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32397911</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>mBio. 2020 Feb 11;11(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32047128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2011 Sep;121(9):3554-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21804191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antibiot (Tokyo). 2019 Oct;72(10):759-768</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31300721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2020 Aug;56(2):105984</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32305589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449-463</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28769016</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Lung Cell Mol Physiol. 2015 Jul 1;309(1):L11-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25957291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Mar 27;11(1):1620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32221306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 May 28;11:1229</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32574272</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Haemost. 2020 May;18(5):1094-1099</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32220112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Jul;96:607-609</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32437934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Feb 26;11(1):1058</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32103002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 May 28;181(5):1036-1045.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32416070</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2020 Jul 1;180(7):934-943</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32167524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Poverty. 2020 Apr 28;9(1):45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32345362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 Jun 10;27(6):891-898.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32413276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autophagy. 2018;14(8):1435-1455</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29940786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Thrombolysis. 2020 Aug;50(2):298-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32476080</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32275812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32142651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2020 Sep;181:104873</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32653452</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2020 May 14;181(4):905-913.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32333836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Drug Investig. 2020 Jun;40(6):511-518</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32337664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscientist. 2020 Jul 13;:1073858420939033</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32659199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pulm Pharmacol Ther. 2020 Aug;63:101942</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32871242</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Transl Med. 2020 Apr 22;18(1):179</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32321524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2020 Jul;17(7):765-767</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32047258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 May 29;11:1131</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32574265</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacokinet. 2013 Sep;52(9):783-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23681967</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33160429</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1646-0758</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>33</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Nov</Month>
                        <Day>02</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Acta medica portuguesa</Title>
                <ISOAbbreviation>Acta Med Port</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Reminder: Cardiovascular Patients Also Benefit from Influenza Vaccine.</ArticleTitle>
            <Pagination>
                <MedlinePgn>782</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.20344/amp.14606</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Alves</LastName>
                    <ForeName>Mariana</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Servi..o de Medicina III. Hospital Pulido Valente. Centro Hospitalar Universit..rio Lisboa Norte. Lisbon; Laboratory of Clinical Pharmacology and Therapeutics. Faculdade de Medicina. Universidade de Lisboa; Instituto de Medicina Molecular. Faculdade de Medicina. Universidade de Lisboa. Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Froes</LastName>
                    <ForeName>Filipe</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Intensive Care Unit. Chest Department. Hospital Pulido Valente. Centro Hospitalar Universit..rio Lisboa Norte. Lisbon. Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caldeira</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Clinical Pharmacology and Therapeutics. Faculdade de Medicina. Universidade de Lisboa. Instituto de Medicina Molecular. Faculdade de Medicina. Universidade de Lisboa. Servi..o de Cardiologia. Hospital Universit..rio de Santa Maria. Centro Hospitalar Universit..rio Lisboa Norte. Lisboa. Centro Cardiovascular da Universidade de Lisboa (CCUL). Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Portugal</Country>
            <MedlineTA>Acta Med Port</MedlineTA>
            <NlmUniqueID>7906803</NlmUniqueID>
            <ISSNLinking>0870-399X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Cardiovascular Diseases</Keyword>
            <Keyword MajorTopicYN="N">Common Cold</Keyword>
            <Keyword MajorTopicYN="N">Influenza Vaccines</Keyword>
            <Keyword MajorTopicYN="N">Influenza, Human</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>20</Hour>
                <Minute>21</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33160429</ArticleId>
            <ArticleId IdType="doi">10.20344/amp.14606</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33160207</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>22</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2352-3964</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>62</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>EBioMedicine</Title>
                <ISOAbbreviation>EBioMedicine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>103101</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S2352-3964(20)30477-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2020.103101</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Reliable high-throughput serological assays for SARS-CoV-2 antibodies are urgently needed for the effective containment of the COVID-19 pandemic, as it is of crucial importance to understand the strength and duration of immunity after infection, and to make informed decisions concerning the activation or discontinuation of physical distancing restrictions.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In 184 serum samples from 130 COVID-19 patients and 54 SARS-CoV-2 negative subjects, the analytical and clinical performances of four commercially available chemiluminescent assays (Abbott SARS-Cov-2 IgG, Roche Elecsys anti-SARS-CoV-2, Ortho SARS-CoV-2 total and IgG) and one enzyme-linked immunosorbent assay (Diesse ENZY-WELL SARS-CoV-2 IgG) were evaluated and compared with the neutralization activity achieved using the plaque reduction neutralization test (PRNT).</AbstractText>
                <AbstractText Label="FINDINGS" NlmCategory="RESULTS">Precision results ranged from 0.9% to 11.8% for all assays. Elecsys anti-SARS-CoV-2 demonstrated linearity of results at concentrations within the cut-off value. Overall, sensitivity ranged from 78.5 to 87.7%, and specificity, from 97.6 to 100%. On limiting the analysis to samples collected 12 days after onset of symptoms, the sensitivity of all assays increased, the highest value (95.2%) being obtained with VITRO Anti-SARS-CoV-2 Total and Architect SARS-CoV-2 IgG. The strongest PRNT<sub>50</sub> correlation with antibody levels was obtained with ENZY-Well SARS-CoV-2 IgG (R<sup>2</sup>adj..=..0.569).</AbstractText>
                <AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">The results confirmed that all immunoassays had an excellent specificity, whereas sensitivity varied across immunoassays, depending strongly on the time interval between symptoms onset and sample collection. Further studies should be conducted to achieve a stronger correlation between antibody measurement and PRNT<sub>50</sub> in order to obtain useful information for providing a better management of COVID-19 patients, effective passive antibody therapy, and developing a vaccine against the SARS-CoV-2 virus.</AbstractText>
                <AbstractText Label="FUNDING" NlmCategory="BACKGROUND">None.</AbstractText>
                <CopyrightInformation>Copyright .. 2020 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Padoan</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine-DIMED, Medical School, University of Padova, Italy; Department of Laboratory Medicine, University-Hospital of Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bonfante</LastName>
                    <ForeName>Francesco</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pagliari</LastName>
                    <ForeName>Matteo</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bortolami</LastName>
                    <ForeName>Alessio</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Negrini</LastName>
                    <ForeName>Davide</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine-DIMED, Medical School, University of Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zuin</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine-DIMED, Medical School, University of Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bozzato</LastName>
                    <ForeName>Dania</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine-DIMED, Medical School, University of Padova, Italy; Department of Laboratory Medicine, University-Hospital of Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cosma</LastName>
                    <ForeName>Chiara</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, University-Hospital of Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sciacovelli</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, University-Hospital of Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plebani</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine-DIMED, Medical School, University of Padova, Italy; Department of Laboratory Medicine, University-Hospital of Padova, Italy. Electronic address: mario.plebani@unipd.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016430">Clinical Trial</PublicationType>
                <PublicationType UI="D003160">Comparative Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>EBioMedicine</MedlineTA>
            <NlmUniqueID>101647039</NlmUniqueID>
            <ISSNLinking>2352-3964</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="Y">Antibodies, Neutralizing</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000087124" MajorTopicYN="Y">COVID-19 Serological Testing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antibodies</Keyword>
            <Keyword MajorTopicYN="N">Clinical performances</Keyword>
            <Keyword MajorTopicYN="N">Immunoassays</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">Serology</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>20</Hour>
                <Minute>15</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33160207</ArticleId>
            <ArticleId IdType="pii">S2352-3964(20)30477-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ebiom.2020.103101</ArticleId>
            <ArticleId IdType="pmc">PMC7640894</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32172228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32584464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 29;383(18):1724-1734</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32871063</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Oct;92(10):2243-2247</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32510168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2020 Sep;26(9):1256.e9-1256.e11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32531475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chem. 2020 Sep 07;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32894750</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Aug;129:104512</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32563180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jun 9;323(22):2249-2251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32374370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Sep 10;383(11):1085-1087</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32706954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 Jul 23;58(8):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32513859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2020 May 26;12(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32466458</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chem Lab Med. 2020 Sep 25;58(10):e189-e191</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32619192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 2020 Aug;507:164-166</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32343948</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Jun;26(6):845-848</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32350462</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Apr;25(16):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32347204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Aug;129:104540</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32652475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1081-1088</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32301749</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Aug;129:104480</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32505777</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Sep;130:104549</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32763809</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jun 5;368(6495):1060-1061</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32414781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 2020 Oct;509:1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32485157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biologicals. 2012 Nov;40(6):399-404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23034357</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">33156564</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1742-1241</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of clinical practice</Title>
                <ISOAbbreviation>Int J Clin Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e13825</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.13825</ELocationID>
            <Abstract>
                <AbstractText>At present, neither specific antiviral drugs, nor vaccine is recommended for coronavirus disease 2019 (COVID-19) treatment. In this review we discuss the drugs suggested as therapy for COVID-19 infection, with a focus on chloroquine and hydroxychloroquine. The list of drugs used for COVID-19 treatment includes a combination of lopinavir and ritonavir, remdesivir, favipiravir, alpha-interferon, ribavirin, atazanavir, umifenovir, and tocilizumab. As their efficacy and safety are under investigation, none of the regulatory agencies approved them for the treatment of COVID-19 infection. Although chloroquine and hydroxychloroquine possess antiviral and immunomodulatory effects, in practice benefit of their use for COVID-19 treatment is controversial. Several studies investigating hydroxychloroquine were stopped and the French national medicines regulator..suspended its use in clinical trials because of safety concerns. The results from the double-blind, randomised clinical trials, including large number of participants, will add better insight into the role of these two drugs as already available and affordable, antimalarial therapy. The ethical issue on emergency use of chloroquine and hydroxychloroquine in the settings of COVID-19 should be carefully managed, with adherence to the &quot;monitored emergency use of unregistered and experimental interventions&quot; (MEURI) framework or be ethically approved as a trial, as stated by the WHO. Potential shortage of chloroquine/hydroxychloroquine on the market can be overbridged with regular prescriptions by medical doctors and national drug agency should ensure sufficient quantities of these drugs for standard indications.</AbstractText>
                <CopyrightInformation>.. 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dragojevic Simic</LastName>
                    <ForeName>Viktorija</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1979-0762</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Center for Clinical Pharmacology, Military Medical Academy, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miljkovic</LastName>
                    <ForeName>Milijana</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Clinical Pharmacology, Military Medical Academy, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stamenkovic</LastName>
                    <ForeName>Dusica</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-4121-1966</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Anesthesiology and Intensive Care, Military Medical Academy, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vekic</LastName>
                    <ForeName>Berislav</ForeName>
                    <Initials>B</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2458-2282</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, Clinical Center Dr. Dragisa Misovic, Kragujevac, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Ministry of Health of the Republic of Serbia, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ratkovic</LastName>
                    <ForeName>Nenad</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sector for Treatment, Military Medical Academy, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simic</LastName>
                    <ForeName>Radoje</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department for Plastic Surgery, Institute for Mother and Child Health Care of Serbia Dr. Vukan Cupic, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rancic</LastName>
                    <ForeName>Nemanja</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-5122-8094</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Center for Clinical Pharmacology, Military Medical Academy, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>175014</GrantID>
                    <Agency>Ministry of Education, Science and Technological Development of the Republic of Serbia</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>175093</GrantID>
                    <Agency>Ministry of Education, Science and Technological Development of the Republic of Serbia</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Int J Clin Pract</MedlineTA>
            <NlmUniqueID>9712381</NlmUniqueID>
            <ISSNLinking>1368-5031</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>12</Hour>
                <Minute>15</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33156564</ArticleId>
            <ArticleId IdType="doi">10.1111/ijcp.13825</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>References</Title>
            <Reference>
                <Citation>Adhikari SP, Meng S, Wu Y-J, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9:29. https://doi.org/10.1186/s40249-020-00646-x</Citation>
            </Reference>
            <Reference>
                <Citation>Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020;20:124-127. https://doi.org/10.7861/clinmed.2019-coron</Citation>
            </Reference>
            <Reference>
                <Citation>Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. https://doi.org/10.1016/j.jaut.2020.102433</Citation>
            </Reference>
            <Reference>
                <Citation>The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China, 2020. China CDC Weekly. 2020;2:113-122. https://doi.org/10.46234/ccdcw2020.032</Citation>
            </Reference>
            <Reference>
                <Citation>Severe acute respiratory infections treatment Centre: practical manual to set up and manage a SARI treatment centre and SARI screening facility in health care facilities. Geneva: World Health Organization; 2020. https://apps.who.int/iris/bitstream/handle/10665/331603/WHO-2019-nCoV-SARI_treatment_center-2020.1-eng.pdf?sequence=1&amp;isAllowed=y. Accessed June 23, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>UpToData: McIntosh K, Hirsch M, Bloom A. Coronavirus disease 2019 (COVID-19): Clinical features; 2020. https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19. Accessed June 23, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>He F, Deng Y, Li W. Coronavirus disease 2019: What we know? J Med Virol. 2020;92:719-725. https://doi.org/10.1002/jmv.25766</Citation>
            </Reference>
            <Reference>
                <Citation>Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK554776/. Accessed June 28, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020;92:479-490. https://doi.org/10.1002/jmv.25707</Citation>
            </Reference>
            <Reference>
                <Citation>Liu W, Li H. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. [ChemRxivTM-Preprint]. https://chemrxiv.org/articles/COVID-19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173. Accessed June 28, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Popov D. Treatment of Covid-19 Infection. A Rationale for current and future pharmacological approach. EC Pulmonol Respir Med. 2020;9:38-58.</Citation>
            </Reference>
            <Reference>
                <Citation>Rebelem: Rezai S. COVID-19: Clinical/therapeutic staging proposal and treatment; 2020. https://rebelem.com/covid-19-clinical-therapeutic-staging-proposal-and-treatment/. Accessed June 22, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance; 2020. https://apps.who.int/iris/handle/10665/331446?search-result=true&amp;query=10665%2F331446&amp;scope=&amp;rpp=10&amp;sort_by=score&amp;order=desc. Accessed June 22, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Jin Y-H, Cai L, Cheng Z-S, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4. https://doi.org/10.1186/s40779-020-0233-6</Citation>
            </Reference>
            <Reference>
                <Citation>Johns Hopkins University Coronavirus Resource Center. Mortality Analyses. https://coronavirus.jhu.edu/data/mortality. Accessed June 22, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5</Citation>
            </Reference>
            <Reference>
                <Citation>World Health Organization. Novel coronavirus (2019-nCoV) situation Report-8; 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200128-sitrep-8-ncov-cleared.pdf?sfvrsn=8b671ce5_2. Accessed June 20, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Liverpul drug interactions group. Interactions with experimental COVID-19 Therapies; 2020. https://www.sefq.es/_pdfs/CV19_19.pdf. Accessed June 20, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Medicines and Medical Devices Agency of Serbia. Summary of product characteristics: Aluvia..: lopinavir/ritonavir; 2019. https://www.alims.gov.rs/ciril/files/lekovi/smpc/515-01-02931-18-001.pdf. Accessed June 20, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Medicines and Medical Devices Agency of Serbia. Summary of product characteristics: Actemra..: tocilizumab; 2019. https://www.alims.gov.rs/ciril/files/lekovi/smpc/515-01-02510-19-001.pdf. Accessed June 20, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Medicines and Medical Devices Agency of Serbia. Summary of product characteristics: Copegus..: ribavirin; 2019. https://www.alims.gov.rs/ciril/files/lekovi/smpc/515-01-01427-18-001.pdf. Accessed June 20, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>ClinicalTrials.gov. Tocilizumab in COVID-19 pneumonia (TOCIVID-19). https://clinicaltrials.gov/ct2/show/NCT04317092. Accessed June 29, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Drugs.com. Atazanavir side effects. Last updated on May 24, 2019. https://www.drugs.com/sfx/atazanavir-side-effects.html. Accessed June 29, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Drugs.com. Hydroxychloroquine; 2020. https://www.drugs.com/ppa/hydroxychloroquine.html. Accessed June 29, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Drugs.com. Chloroquine side effects; 2019. https://www.drugs.com/sfx/chloroquine-side-effects.html. Accessed June 29, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>European Medicines Agency. Summary of product characteristics: IntronA: recombinant interferon alfa-2b. https://www.ema.europa.eu/en/documents/product-information/introna-epar-product-information_en.pdf. Accessed June 29, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Bergin C, Philbin M, Gilvarry P, O...Connor M, King F.Protocol: Specific Antiviral Therapy in the Clinical Management of Acute Respiratory Infection with SARSCoV-2 (COVID-19); 2020. https://www.hse.ie/eng/about/who/acute-hospitals-division/drugs-management-programme/guidelines/specific-antiviral-therapy-in-the-clinical-management-of-acute-respiratory-infection-with-sars-cov-2-covid-19.pdf. Accessed June 29, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>European Medicines Agency. Summary of product characteristics: Ribavirin Teva Pharma B.V: ribavirin. https://www.ema.europa.eu/en/documents/product-information/ribavirin-teva-pharma-bv-epar-product-information_en.pdf. Accessed June 27, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>European Medicines Agency. Summary of product characteristics: Reyataz: atazanavir. https://www.ema.europa.eu/en/documents/product-information/reyataz-epar-product-information_en.pdf. Accessed June 27, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Van Ierssel S, Dauby N, Bottieau E. Interim clinical guidance for adults with suspected or confirmed covid-19 in Belgium; 2020. Version 7. https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_InterimGuidelines_Treatment_ENG.pdf. Accessed May 20, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Smith T, Bushek J, LeClaire A, Prosser T. COVID-19 drug therapy; 2020. https://www.elsevier.com/__data/assets/pdf_file/0007/988648/COVID-19-Drug-Therapy_2020-6-17.pdf. Accessed May 20, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Instruction for medical use of arbidol. http://www.arbidol.org/dosage.pdf. Accessed May 20, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55:105954. https://doi.org/10.1016/j.ijantimicag.2020.105954</Citation>
            </Reference>
            <Reference>
                <Citation>Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269-271. https://doi.org/10.1038/s41422-020-0282-0</Citation>
            </Reference>
            <Reference>
                <Citation>Kadam RU, Wilson IA. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc Natl Acad Sci USA. 2017;114:206-214. https://doi.org/10.1073/pnas.1617020114</Citation>
            </Reference>
            <Reference>
                <Citation>Warren TK, Jordan R, Lo MK, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Version 2. Nature. 2016;531:381-385. https://doi.org/10.1038/nature17180</Citation>
            </Reference>
            <Reference>
                <Citation>Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). JAMA. 2020;323:1824-1836. https://doi.org/10.1001/jama.2020.6019</Citation>
            </Reference>
            <Reference>
                <Citation>Ministry of Health Serbia. Diagnosis &amp; Treatment Protocol for COVID-19; 2020. [Internal Document].</Citation>
            </Reference>
            <Reference>
                <Citation>Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020:ciaa478. https://doi.org/10.1093/cid/ciaa478</Citation>
            </Reference>
            <Reference>
                <Citation>Van Ierssel S, Dauby N, Bottieau E. Interim Clinical Guidance for adults with suspected or confirmed covid-19 in Belgium; 2020. Version 9. https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_InterimGuidelines_Treatment_ENG.pdf. Accessed May 30, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>National Institutes of Health: COVID-19 Treatment Guidelines. Coronavirus Disease 2019 (COVID-19) treatment guidelines; 2020. https://www.covid19treatmentguidelines.nih.gov/. Accessed June 30, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Vinetz JM. Chemotherapy of malaria. In: Brunton LL, ed. Goodman and Gilman...s Pharmacological basis of therapeutics, 13th edn. New York, NY: McGraw-Hill Education; 2018:969-986.</Citation>
            </Reference>
            <Reference>
                <Citation>Fox RI. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum. 1993;23:82-91. https://doi.org/10.1016/s0049-0172(10)80012-5</Citation>
            </Reference>
            <Reference>
                <Citation>Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003;3:722-727. https://doi.org/10.1016/s1473-3099(03)00806-5</Citation>
            </Reference>
            <Reference>
                <Citation>Blau DM, Holmes KV. Human Coronavirus HCoV-229E enters susceptible cells via the endocytic pathway. In: Lavi E, Weiss SR, Hingley ST, ed. The nidoviruses, coronaviruses and arteriviruses. New York, NY: Kluwer; 2001:193-197.</Citation>
            </Reference>
            <Reference>
                <Citation>Nauwynck HJ, Duan X, Favoreel HW, Van Oostveldt P, Pensaert MB. Entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages via receptor-mediated endocytosis. J Gen Virol. 1999;80:297-305. https://doi.org/10.1099/0022-1317-80-2-297</Citation>
            </Reference>
            <Reference>
                <Citation>Vincent MJ, Bergeron E, Benjannet S, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69. https://doi.org/10.1186/1743-422X-2-69</Citation>
            </Reference>
            <Reference>
                <Citation>Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323:264-268. https://doi.org/10.1016/j.bbrc.2004.08.085</Citation>
            </Reference>
            <Reference>
                <Citation>Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450-454. https://doi.org/10.1038/nature02145</Citation>
            </Reference>
            <Reference>
                <Citation>Xu X, Chen P, Wang J, et al. Evolution of the novel corona virus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63:457-460. https://doi.org/10.1007/s11427-020-1637-5</Citation>
            </Reference>
            <Reference>
                <Citation>Mackenzie AH. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med. 1983;75:40-45. https://doi.org/10.1016/0002-9343(83)91269-x</Citation>
            </Reference>
            <Reference>
                <Citation>Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(15):732-739. https://doi.org/10.1093/cid/ciaa237</Citation>
            </Reference>
            <Reference>
                <Citation>McChesney EW. Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med. 1983;75:11-18. https://doi.org/10.1016/0002-9343(83)91265-2</Citation>
            </Reference>
            <Reference>
                <Citation>McChesney EW, Banks WF Jr, Sullivan DJ. Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats. Toxicol Appl Pharmacol. 1965;7:627-636. https://doi.org/10.1016/0041-008x(65)90050-5</Citation>
            </Reference>
            <Reference>
                <Citation>McChesney EW, McAuliff JP. Laboratory studies of the 4-aminoquinoline antimalarials. I Some biochemical characteristics of chloroquine, hydroxychloroquine and SN-7718. Antibiot Chemother. 1961;11:800-810.</Citation>
            </Reference>
            <Reference>
                <Citation>Singh AK, Singh A, Shaikh A, Singh R, Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr. 2020;14:241-246. https://doi.org/10.1016/j.dsx.2020.03.011</Citation>
            </Reference>
            <Reference>
                <Citation>Marmor MF, Kellner U, Lai TY, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology. 2016;123:1386-1394. https://doi.org/10.1016/j.ophtha.2016.01.058</Citation>
            </Reference>
            <Reference>
                <Citation>Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology. 2015;23:231-269. https://doi.org/10.1007/s10787-015-0239-y</Citation>
            </Reference>
            <Reference>
                <Citation>Perinel S, Launay M, Botelho-Nevers .., et al. Towards optimization of hydroxychloroquine dosing in intensive care unit COVID-19 patients. Clin Infect Dis. 2020:ciaa394. https://doi.org/10.1093/cid/ciaa394</Citation>
            </Reference>
            <Reference>
                <Citation>Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14:72-73. https://doi.org/10.5582/bst.2020.01047</Citation>
            </Reference>
            <Reference>
                <Citation>Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;105949. https://doi.org/10.1016/j.ijantimicag.2020.105949</Citation>
            </Reference>
            <Reference>
                <Citation>Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020;57:279-283. https://doi.org/10.1016/j.jcrc.2020.03.005</Citation>
            </Reference>
            <Reference>
                <Citation>Kapoor KM, Kapoor A. Role of chloroquine and hydroxychloroquine in the treatment of COVID-19 infection-A systematic literature review. MedRxiv. 2020. https://doi.org/10.1101/2020.03.24.20042366. [Preprint]. https://www.medrxiv.org/content/10.1101/2020.03.24.20042366v1. Accessed June 30, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Jie Z, He H, Xi H, Zhi Z. Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia. Expert Consensus on Chloroquine Phosphate for the Treatment of Novel Coronavirus Pneumonia. 2020;43:185-188. Chinese. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.03.009</Citation>
            </Reference>
            <Reference>
                <Citation>Chen J, Liu D, Liu L, et al. A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49:215-219. Chinese.</Citation>
            </Reference>
            <Reference>
                <Citation>Tang W, Cao Z, Han M, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020;369:m1849. https://doi.org/10.1136/bmj.m1849</Citation>
            </Reference>
            <Reference>
                <Citation>Borba MGS, Val FFA, Sampaio VS, et al. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open. 2020;3:e208857. https://doi.org/10.1001/jamanetworkopen.2020.8857</Citation>
            </Reference>
            <Reference>
                <Citation>Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D, et al.Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. MedRxiv. 2020. [Preprint]. https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v3. Accessed June 28, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Medicines &amp; Healthcare products Regulatory Agency. Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment; 2020. https://www.gov.uk/government/news/chloroquine-and-hydroxychloroquine-not-licensed-for-coronavirus-covid-19-treatment. Accessed May 30, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>U.S. Food and Drug Administration. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or. Accessed May 30, 2020</Citation>
            </Reference>
            <Reference>
                <Citation>European Medicines Agency. Science Medical Health. COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes; 2020. https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes. Accessed May 30, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;S0140-6736(20):31180-31186. https://doi.org/10.1016/S0140-6736(20)31180-6. Retraction in: Lancet. 2020;null.</Citation>
            </Reference>
            <Reference>
                <Citation>World Health Organization. ...Solidarity... clinical trial for COVID-19 treatments; 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments. Accessed May 30, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>RECOVERY Randomized evaluation of COVID-19 Therapy. Recruitment to the RECOVERY trial continues as planned. 2020. https://www.recoverytrial.net/news/recruitment-to-the-recovery-trial-continues-as-planned. Accessed May 30, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>RECOVERY Randomized evaluation of COVID-19 Therapy. Randomized evaluation of COVID 19 therapy. https://www.recoverytrial.net/files/recovery-protocol-v6-0-2020-05-14.pdf. Accessed June 15, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>POLITICO. France bans use of hydroxychloroquine as coronavirus treatment. 2020. https://www.politico.com/news/2020/05/27/france-bans-use-of-hydroxychloroquine-to-cure-coronavirus-283724. Accessed June 15, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>COVID-19: l...ANSM souhaite suspendre par pr..caution les essais cliniques ..valuant l...hydroxychloroquine dans la prise en charge des patients-Point d'Information; 2020. https://www.ansm.sante.fr/S-informer/Points-d-information-Points-d-information/COVID-19-l-ANSM-souhaite-suspendre-par-precaution-les-essais-cliniques-evaluant-l-hydroxychloroquine-dans-la-prise-en-charge-des-patients-Point-d-Information. Accessed on June 1, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>National Institutes of Health. NIH halts clinical trial of hydroxychloroquine; 2020. https://www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine. Accessed June 22, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>van den Broek MPH, M..hlmann JE, Abeln BGS, et al. Chloroquine-induced QTc prolongation in COVID-19 patients. Neth Heart J. 2020;1-4. https://doi.org/10.1007/s12471-020-01429-7</Citation>
            </Reference>
            <Reference>
                <Citation>Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;382:2411-2418. https://doi.org/10.1056/NEJMoa2012410</Citation>
            </Reference>
            <Reference>
                <Citation>Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020;383(6):517-525. https://doi.org/10.1056/NEJMoa2016638</Citation>
            </Reference>
            <Reference>
                <Citation>World Health Organization. Guidance for managing ethical issues in infectious disease outbreaks. Spain: World Health Organization; 2016. https://apps.who.int/iris/handle/10665/250580. Accessed May 30, 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Yazdany J, Kim AHJ. Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: What every clinician should know. Ann Intern Med. 2020;172:754-755. https://doi.org/10.7326/M20-1334</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33154276</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1117-1936</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>27</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <MedlineDate>2020 Oct-Dec</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>The Nigerian postgraduate medical journal</Title>
                <ISOAbbreviation>Niger Postgrad Med J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19: A review of the effectiveness of non-pharmacological interventions.</ArticleTitle>
            <Pagination>
                <MedlinePgn>261-267</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4103/npmj.npmj_208_20</ELocationID>
            <Abstract>
                <AbstractText>COVID-19, a highly infectious disease, caused by a novel virus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought about an unprecedented threat to global health. First reported in Wuhan, China, in December 2019, it has now spread to all continents of the world becoming a pandemic. There is no known treatment or vaccine for it although many candidate drugs and vaccines are in various clinical trial phases. For now, non-pharmacological interventions (NPIs) have become the mainstay of response for COVID-19 and are being used across the world to flatten the epidemiologic curve with some success. This review focussed on identifying which NPIs have been effective. NPIs that are effective include isolation and quarantine, physical distancing, use of face masks and hand hygiene. These measures are best used in combination and simultaneously. The evidence is that they should be instituted early in the pandemic and for sustained periods. They should also be implemented in the context of the cultural and socioeconomic conditions of the populace. Ineffective NPIs include ultraviolet irradiation and spraying of outdoor spaces and individuals. We recommend that decision makers weigh the evidence carefully, as it applies to the local setting to inform public health decisions.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Odusanya</LastName>
                    <ForeName>Olumuyiwa O</ForeName>
                    <Initials>OO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health and Primary Health Care, Lagos State University College of Medicine, Ikeja, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Odugbemi</LastName>
                    <ForeName>Babatunde A</ForeName>
                    <Initials>BA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health and Primary Health Care, Lagos State University College of Medicine, Ikeja, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Odugbemi</LastName>
                    <ForeName>Tinuola O</ForeName>
                    <Initials>TO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Health and Primary Care, College of Medicine of the University of Lagos, Lagos, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ajisegiri</LastName>
                    <ForeName>Whenayon S</ForeName>
                    <Initials>WS</Initials>
                    <AffiliationInfo>
                        <Affiliation>The George Institute for Global Health, University of New South Wales, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Nigeria</Country>
            <MedlineTA>Niger Postgrad Med J</MedlineTA>
            <NlmUniqueID>9613595</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063373" MajorTopicYN="N">Hand Hygiene</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008397" MajorTopicYN="N">Masks</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012934" MajorTopicYN="N">Social Isolation</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Coronavirus disease 2019</Keyword>
            <Keyword MajorTopicYN="N">epidemic</Keyword>
            <Keyword MajorTopicYN="N">non-pharmacological interventions</Keyword>
            <Keyword MajorTopicYN="N">pandemic</Keyword>
            <Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus-2</Keyword>
        </KeywordList>
        <CoiStatement>None</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>5</Hour>
                <Minute>52</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33154276</ArticleId>
            <ArticleId IdType="pii">NigerPostgradMedJ_2020_27_4_261_299904</ArticleId>
            <ArticleId IdType="doi">10.4103/npmj.npmj_208_20</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33151142</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1465-2099</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>102</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of general virology</Title>
                <ISOAbbreviation>J Gen Virol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1099/jgv.0.001513</ELocationID>
            <Abstract>
                <AbstractText>The emerging pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused social and economic disruption worldwide, infecting over 9.0...million people and killing over 469...000 by 24 June 2020. Unfortunately, no vaccine or antiviral drug that completely eliminates the transmissible disease coronavirus disease 2019 (COVID-19) has been developed to date. Given that coronavirus nonstructural protein 1 (nsp1) is a good target for attenuated vaccines, it is of great significance to explore the detailed characteristics of SARS-CoV-2 nsp1. Here, we first confirmed that SARS-CoV-2 nsp1 had a conserved function similar to that of SARS-CoV nsp1 in inhibiting host-protein synthesis and showed greater inhibition efficiency, as revealed by ribopuromycylation and Renilla luciferase (Rluc) reporter assays. Specifically, bioinformatics and biochemical experiments showed that by interacting with 40S ribosomal subunit, the lysine located at amino acid 164 (K164) was the key residue that enabled SARS-CoV-2 nsp1 to suppress host gene expression. Furthermore, as an inhibitor of host-protein expression, SARS-CoV-2 nsp1 contributed to cell-cycle arrest in G0/G1 phase, which might provide a favourable environment for virus production. Taken together, this research uncovered the detailed mechanism by which SARS-CoV-2 nsp1 K164 inhibited host gene expression, laying the foundation for the development of attenuated vaccines based on nsp1 modification.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Zhou</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, PR China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Guangxu</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Yilin</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, PR China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Mengxia</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, PR China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Siqi</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peng</LastName>
                    <ForeName>Guiqing</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, PR China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Gen Virol</MedlineTA>
            <NlmUniqueID>0077340</NlmUniqueID>
            <ISSNLinking>0022-1317</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000706293">NSP1 protein, SARS-CoV-2</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012269">Ribosomal Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.13.12.-</RegistryNumber>
                <NameOfSubstance UI="D008156">Luciferases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>K3Z4F929H6</RegistryNumber>
                <NameOfSubstance UI="D008239">Lysine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059585" MajorTopicYN="N">G1 Phase Cell Cycle Checkpoints</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008239" MajorTopicYN="N">Lysine</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012269" MajorTopicYN="N">Ribosomal Proteins</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D054682" MajorTopicYN="N">Ribosome Subunits, Small, Eukaryotic</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">40S ribosomal subunit</Keyword>
            <Keyword MajorTopicYN="Y">Host gene expression inhibition</Keyword>
            <Keyword MajorTopicYN="Y">K164</Keyword>
            <Keyword MajorTopicYN="Y">Nonstructural protein 1</Keyword>
            <Keyword MajorTopicYN="Y">Severe acute respiratory syndrome coronavirus 2</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>2</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>12</Hour>
                <Minute>11</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33151142</ArticleId>
            <ArticleId IdType="doi">10.1099/jgv.0.001513</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33150094</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2167-8359</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PeerJ</Title>
                <ISOAbbreviation>PeerJ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Computerized monitoring of COVID-19 trials, studies and registries in ClinicalTrials.gov registry.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e10261</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj.10261</ELocationID>
            <Abstract>
                <AbstractText>Clinical trial registries can provide important information about relevant studies for a given condition to other researchers and the public. We developed a computerized informatics based approach to provide an overview and analysis of COVID-19 studies registered on ClinicalTrials.gov registry. Using the perspective of analyzing active or completed COVID-19 studies, we identified 401 interventional clinical trials, 287 observational studies and 64 registries. We analyzed features of each study type separately such as location, design, interventions and update history. Our results show that the United States had the most COVID-19 interventional trials, France had the most COVID-19 observational studies and France and the United States tied for the most COVID-19 registries on ClinicalTrials.gov. The majority of studies in all three study types had a single study site. For update history &quot;Study Status&quot; is the most updated information and we found that studies located in Canada (2.70 updates per study) and the United States (1.76 updates per study) update their studies more often than studies in any other country. Using normalization and mapping techniques, we identified Hydroxychloroquine (92 studies) as the most common drug intervention, while convalescent plasma (20 studies) is the most common biological intervention. The primary purpose of most interventional trials is for treatment with 298 studies (74.3%). For COVID-19 registries we found the most common proposed follow-up time is 1 year (15 studies). Of specific importance and interest is COVID-19 vaccine trials, of which 12 were identified. Our informatics based approach allows for constant monitoring and updating as well as multiple applications to other conditions and interests.</AbstractText>
                <CopyrightInformation>.. 2020 Mayer and Huser.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mayer</LastName>
                    <ForeName>Craig S</ForeName>
                    <Initials>CS</Initials>
                    <Identifier Source="ORCID">0000-0002-2705-9550</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Lister Hill National Center for Biomedical Communication, National Library of Medicine, NIH, Bethesda, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huser</LastName>
                    <ForeName>Vojtech</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">0000-0002-0709-6573</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Lister Hill National Center for Biomedical Communication, National Library of Medicine, NIH, Bethesda, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016430">Clinical Trial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PeerJ</MedlineTA>
            <NlmUniqueID>101603425</NlmUniqueID>
            <ISSNLinking>2167-8359</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Clinical trials</Keyword>
            <Keyword MajorTopicYN="N">Data science</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>8</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33150094</ArticleId>
            <ArticleId IdType="doi">10.7717/peerj.10261</ArticleId>
            <ArticleId IdType="pii">10261</ArticleId>
            <ArticleId IdType="pmc">PMC7587053</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Microbiol Infect. 2020 Aug;26(8):988-998</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32454187</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Trials. 2013 Apr;10(2):347-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23539114</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2019 Nov 14;381(20):1966-1974</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31722160</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2018 Mar 7;13(3):e0193088</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29513684</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Med Inform Assoc. 2013 Jun;20(e1):e169-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23396544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Panam Salud Publica. 2020 Mar 20;44:e40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32256547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Med Inform Assoc. 2009 May-Jun;16(3):316-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19261934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Panminerva Med. 2020 May 26;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32456404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BioData Min. 2020 May 12;13:3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32419848</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33144321</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>22</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Electronic-Print">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>95</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>01</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J Virol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">e01828-20</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01828-20</ELocationID>
            <Abstract>
                <AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody responses to the spike (S) protein monomer, S protein native trimeric form, or the nucleocapsid (N) proteins were evaluated in cohorts of individuals with acute infection (<i>n</i>...=...93) and in individuals enrolled in a postinfection seroprevalence population study (<i>n</i>...=...578) in Switzerland. Commercial assays specific for the S1 monomer, for the N protein, or within a newly developed Luminex assay using the S protein trimer were found to be equally sensitive in antibody detection in the acute-infection-phase samples. Interestingly, compared to anti-S antibody responses, those against the N protein appear to wane in the postinfection cohort. Seroprevalence in a &quot;positive patient contacts&quot; group (<i>n</i>...=...177) was underestimated by N protein assays by 10.9 to 32.2%, while the &quot;randomly selected&quot; general population group (<i>n</i>...=...311) was reduced by up to 45% relative to the S protein assays. The overall reduction in seroprevalence targeting only anti-N antibodies for the total cohort ranged from 9.4 to 31%. Of note, the use of the S protein in its native trimer form was significantly more sensitive compared to monomeric S proteins. These results indicate that the assessment of anti-S IgG antibody responses against the native trimeric S protein should be implemented to estimate SARS-CoV-2 infections in population-based seroprevalence studies.<b>IMPORTANCE</b> In the present study, we have determined SARS-CoV-2-specific antibody responses in sera of acute and postinfection phase subjects. Our results indicate that antibody responses against viral S and N proteins were equally sensitive in the acute phase of infection, but that responses against N appear to wane in the postinfection phase where those against the S protein persist over time. The most sensitive serological assay in both acute and postinfection phases used the native S protein trimer as the binding antigen, which has significantly greater conformational epitopes for antibody binding compared to the S1 monomer protein used in other assays. We believe these results are extremely important in order to generate correct estimates of SARS-CoV-2 infections in the general population. Furthermore, the assessment of antibody responses against the trimeric S protein will be critical to evaluate the durability of the antibody response and for the characterization of a vaccine-induced antibody response.</AbstractText>
                <CopyrightInformation>Copyright .. 2021 Fenwick et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Fenwick</LastName>
                    <ForeName>Craig</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">0000-0002-9435-0110</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Croxatto</LastName>
                    <ForeName>Antony</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Coste</LastName>
                    <ForeName>Alix T</ForeName>
                    <Initials>AT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Pojer</LastName>
                    <ForeName>Florence</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Protein Production and Structure Core Facility, School of Life Sciences, ..cole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andr..</LastName>
                    <ForeName>Cyril</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pellaton</LastName>
                    <ForeName>C..line</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Farina</LastName>
                    <ForeName>Alex</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Campos</LastName>
                    <ForeName>J..r..my</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hacker</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Protein Production and Structure Core Facility, School of Life Sciences, ..cole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lau</LastName>
                    <ForeName>Kelvin</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Protein Production and Structure Core Facility, School of Life Sciences, ..cole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bosch</LastName>
                    <ForeName>Berend-Jan</ForeName>
                    <Initials>BJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gonseth Nussle</LastName>
                    <ForeName>Semira</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bochud</LastName>
                    <ForeName>Murielle</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>D'Acremont</LastName>
                    <ForeName>Valerie</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trono</LastName>
                    <ForeName>Didier</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Life Sciences, Ecole Polytechnique F..d..rale de Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greub</LastName>
                    <ForeName>Gilbert</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland gilbert.greub@chuv.ch giuseppe.pantaleo@chuv.ch.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pantaleo</LastName>
                    <ForeName>Giuseppe</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">0000-0003-3651-2721</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland gilbert.greub@chuv.ch giuseppe.pantaleo@chuv.ch.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Swiss Vaccine Research Institute, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2021</Year>
                <Month>01</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086462">Coronavirus Nucleocapsid Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000705834">nucleocapsid phosphoprotein, SARS-CoV-2</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086462" MajorTopicYN="N">Coronavirus Nucleocapsid Proteins</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013557" MajorTopicYN="N" Type="Geographic">Switzerland</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">S protein trimer</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">serology</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>1</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>4</Day>
                <Hour>5</Hour>
                <Minute>36</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33144321</ArticleId>
            <ArticleId IdType="pii">JVI.01828-20</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01828-20</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Coronavirus disease (COVID-2019) situation reports-175. 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Norheim OF. Protecting the population with immune individuals. Nat Med. 2020;26:823...824.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41591-020-0896-2</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Phelan AL. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. Lancet. 2020;395:1595...1598.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)31034-5</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Weitz JS, Beckett SJ, Coenen AR, Demory D, Dominguez-Mirazo M, Dushoff J, Leung C-Y, Li G, M..g..lie A, Park SW, Rodriguez-Gonzalez R, Shivam S, Zhao CY. Modeling shield immunity to reduce COVID-19 epidemic spread. Nat Med. 2020;26:849...854.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41591-020-0895-3</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Okba NMA, Muller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken C, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerg Infect Dis. 2020;26:1478...1488.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3201/eid2607.200841</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Li G, Chen X, Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med. 2003;349:508...509.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1056/NEJM200307313490520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S, Hong C, Wang F, Liu Y, Wang Z, He Q, Li Z, He B, Zhang T, Fu Y, Ge S, Liu L, Zhang J, Xia N, Zhang Z. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1093/cid/ciaa344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Meyer B, Drosten C, Muller MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014;194:175...183.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.virusres.2014.03.018</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infantino M, Damiani A, Gobbi FL, Grossi V, Lari B, Macchia D, Casprini P, Veneziani F, Villalta D, Bizzaro N, Cappelletti P, Fabris M, Quartuccio L, Benucci M, Manfredi M. Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives. Isr Med Assoc J. 2020;22:203...210.</Citation>
            </Reference>
            <Reference>
                <Citation>Chia WN, Tan CW, Foo R, Kang AEZ, Peng Y, Sivalingam V, Tiu C, Ong XM, Zhu F, Young BE, Chen MI, Tan YJ, Lye DC, Anderson DE, Wang LF. Serological differentiation between COVID-19 and SARS infections. Emerg Microbes Infect. 2020;9:1497...1505.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1080/22221751.2020.1780951</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cao WC, Liu W, Zhang PH, Zhang F, Richardus JH. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med. 2007;357:1162...1163.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1056/NEJMc070348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Choe PG, Perera R, Park WB, Song KH, Bang JH, Kim ES, Kim HB, Ko LWR, Park SW, Kim NJ, Lau EHY, Poon LLM, Peiris M, Oh MD. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis. 2017;23:1079...1084.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3201/eid2307.170310</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wu LP, Wang NC, Chang YH, Tian XY, Na DY, Zhang LY, Zheng L, Lan T, Wang LF, Liang GD. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13:1562...1564.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3201/eid1310.070576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Payne DC, Iblan I, Rha B, Alqasrawi S, Haddadin A, Al Nsour M, Alsanouri T, Ali SS, Harcourt J, Miao C, Tamin A, Gerber SI, Haynes LM, Al Abdallat MM. Persistence of antibodies against Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016;22:1824...1826.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.3201/eid2210.160706</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Guo X, Guo Z, Duan C, Chen Z, Wang G, Lu Y, Li M, Lu J. Long-term persistence of IgG antibodies in SARS-CoV infected healthcare workers. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.02.12.20021386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. bioRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.02.11.944462</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Coste AT, Jaton K, Papadimitriou-Olivgeris M, Greub G, Croxatto A. Comparison of SARS-CoV-1 2 serological tests with different antigen targets. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.07.09.20149864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kohmer N, Westhaus S, Ruhl C, Ciesek S, Rabenau HF. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. J Clin Virol. 2020;129:104480.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.jcv.2020.104480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Getaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396:313...319.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/S0140-6736(20)31304-0</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Saplakoglu Y. 1 in 5 people tested in New York City had antibodies for the coronavirus. 2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Gobierno de Espa..a, Ministerio de Sanidad. Estudio ENE-COVID19: primera ronda. Estudio nacional de sero-epidemiolog..a de la infecci..n por SARS-CoV-2 en Espa..a.</Citation>
            </Reference>
            <Reference>
                <Citation>Coste AT, Jaton K, Papadimitriou-Olivgeris M, Croxatto A, Greub G. Indication for SARS-CoV-2 serology: first month follow-up. medRxiv. 2020.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1101/2020.06.30.20140715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Montesinos I, Gruson D, Kabamba B, Dahma H, Van den Wijngaert S, Reza S, Carbone V, Vandenberg O, Gulbis B, Wolff F, Rodriguez-Villalobos H. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol. 2020;128:104413.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1016/j.jcv.2020.104413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, Hu JL, Xu W, Zhang Y, Lv FJ, Su K, Zhang F, Gong J, Wu B, Liu XM, Li JJ, Qiu JF, Chen J, Huang AL. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200...1204.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.1038/s41591-020-0965-6</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brunink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:2000045.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.3.2000045</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Greub G, Sahli R, Brouillet R, Jaton K. Ten years of R&amp;D and full automation in molecular diagnosis. Future Microbiol. 2016;11:403...425.</Citation>
                <ArticleIdList>
                    <ArticleId IdType="doi">10.2217/fmb.15.152</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33139139</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>38</Volume>
                    <Issue>50</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>11</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.</ArticleTitle>
            <Pagination>
                <MedlinePgn>7892-7896</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(20)31373-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2020.10.064</ELocationID>
            <Abstract>
                <AbstractText>There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective efficacy of a SARS-CoV-2 subunit vaccine (NVX-CoV2373) produced from the full-length SARS-CoV-2 spike (S) glycoprotein stabilized in the prefusion conformation. Cynomolgus macaques (Macaca fascicularis) immunized with NVX-CoV2373 and the saponin-based Matrix-M... adjuvant induced anti-S antibody that was neutralizing and blocked binding to the human angiotensin-converting enzyme 2 (hACE2) receptor. Following intranasal and intratracheal challenge with SARS-CoV-2, immunized macaques were protected against upper and lower infection and pulmonary disease. These results support ongoing phase 1/2 clinical studies of the safety and immunogenicity of NVX-CoV2327 vaccine (NCT04368988).</AbstractText>
                <CopyrightInformation>Copyright .. 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Guebre-Xabier</LastName>
                    <ForeName>Mimi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: mguebre-xabier@Novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Nita</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: npatel@novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Jing-Hui</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: jhtian@Novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Bin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: bzhou@Novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maciejewski</LastName>
                    <ForeName>Sonia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: smaciejewski@Novavavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lam</LastName>
                    <ForeName>Kristal</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: klam@Novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Portnoff</LastName>
                    <ForeName>Alyse D</ForeName>
                    <Initials>AD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: aportnoff@Novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Massare</LastName>
                    <ForeName>Michael J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: mmassare@Novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frieman</LastName>
                    <ForeName>Matthew B</ForeName>
                    <Initials>MB</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Maryland, School of Medicine, 685 West Baltimore St, Baltimore, MD 21201, USA. Electronic address: mfrieman@som.umaryland.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Piedra</LastName>
                    <ForeName>Pedro A</ForeName>
                    <Initials>PA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX, USA. Electronic address: ppiedra@bcm.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ellingsworth</LastName>
                    <ForeName>Larry</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: lellingsworth@novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Glenn</LastName>
                    <ForeName>Gregory</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: gglenn@Novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Gale</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: gsmith@Novavax.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT04368988</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007106">Immune Sera</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000711928">recombinant SARS-CoV-2 vaccine NVX-cov2373</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.17.23</RegistryNumber>
                <NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.17.23</RegistryNumber>
                <NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007106" MajorTopicYN="N">Immune Sera</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">Matrix-M adjuvant</Keyword>
            <Keyword MajorTopicYN="Y">NVX-CoV2373 nanoparticles</Keyword>
            <Keyword MajorTopicYN="Y">Nonhuman primate</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Spike glycoprotein</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>5</Hour>
                <Minute>36</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33139139</ArticleId>
            <ArticleId IdType="pii">S0264-410X(20)31373-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2020.10.064</ArticleId>
            <ArticleId IdType="pmc">PMC7584426</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32075877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jul 3;369(6499):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):572-577</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32726802</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 May;581(7809):465-469</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32235945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2020 Aug;30(8):670-677</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32636454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Oct;586(7830):578-582</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32731258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Oct 15;383(16):1544-1555</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32722908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Dec 10;383(24):2320-2332</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32877576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):1012-1015</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32303590</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):806-811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32434945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):812-817</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32434946</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">33139059</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-6825</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>147</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of allergy and clinical immunology</Title>
                <ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Eosinophilic pulmonary vasculitis as a manifestation of the hyperinflammatory phase of COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>112-113</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0091-6749(20)31392-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaci.2020.09.026</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Luecke</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany. Electronic address: eva.luecke@med.ovgu.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeron</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infection Immunology Group, Institute for Medical Microbiology and Hospital Hygiene, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; Immune Regulation Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kroeger</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Microbiology Group, Institute for Medical Microbiology and Hospital Hygiene, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bruder</LastName>
                    <ForeName>Dunja</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infection Immunology Group, Institute for Medical Microbiology and Hospital Hygiene, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; Immune Regulation Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stegemann-Koniszewski</LastName>
                    <ForeName>Sabine</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jechorek</LastName>
                    <ForeName>Doerthe</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Borucki</LastName>
                    <ForeName>Katrin</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Clinical Chemistry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reinhold</LastName>
                    <ForeName>Dirk</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reinhold</LastName>
                    <ForeName>Annegret</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Foellner</LastName>
                    <ForeName>Sebastian</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walles</LastName>
                    <ForeName>Thorsten</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiothoracic Surgery, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hachenberg</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anaesthesiology and Intensive Care Therapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schreiber</LastName>
                    <ForeName>Jens</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol</MedlineTA>
            <NlmUniqueID>1275002</NlmUniqueID>
            <ISSNLinking>0091-6749</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>J Allergy Clin Immunol. 2020 Jul;146(1):1-7</RefSource>
                <PMID Version="1">32344056</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004804" MajorTopicYN="N">Eosinophils</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014657" MajorTopicYN="Y">Vasculitis</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>1</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>5</Hour>
                <Minute>35</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33139059</ArticleId>
            <ArticleId IdType="pii">S0091-6749(20)31392-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaci.2020.09.026</ArticleId>
            <ArticleId IdType="pmc">PMC7587128</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2020 Jul;146(1):1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32344056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2021 Feb;76(2):562-564</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32544252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2021 Feb;76(2):471-482</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32562554</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2021 Jan;147(1):107-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32920092</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33138946</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1877-5853</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>35</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>11</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Spatial and spatio-temporal epidemiology</Title>
                <ISOAbbreviation>Spat Spatiotemporal Epidemiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium?</ArticleTitle>
            <Pagination>
                <MedlinePgn>100379</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1877-5845(20)30057-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.sste.2020.100379</ELocationID>
            <Abstract>
                <AbstractText>Although COVID-19 has been spreading throughout Belgium since February, 2020, its spatial dynamics in Belgium remain poorly understood, partly due to the limited testing of suspected cases during the epidemic's early phase. We analyse data of COVID-19 symptoms, as self-reported in a weekly online survey, which is open to all Belgian citizens. We predict symptoms' incidence using binomial models for spatially discrete data, and we introduce these as a covariate in the spatial analysis of COVID-19 incidence, as reported by the Belgian government during the days following a survey round. The symptoms' incidence is moderately predictive of the variation in the relative risks based on the confirmed cases; exceedance probability maps of the symptoms' incidence and confirmed cases' relative risks overlap partly. We conclude that this framework can be used to detect COVID-19 clusters of substantial sizes, but it necessitates spatial information on finer scales to locate small clusters.</AbstractText>
                <CopyrightInformation>Copyright .. 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Neyens</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>I-BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, Hasselt B-3500, Belgium; I-BioStat, Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven, Kapucijnenvoer 35, Leuven B-3000, Belgium. Electronic address: thomas.neyens@uhasselt.be.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Faes</LastName>
                    <ForeName>Christel</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>I-BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, Hasselt B-3500, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vranckx</LastName>
                    <ForeName>Maren</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>I-BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, Hasselt B-3500, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pepermans</LastName>
                    <ForeName>Koen</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, Antwerp 2000, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hens</LastName>
                    <ForeName>Niel</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>I-BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, Hasselt B-3500, Belgium; Center for Health Economics Research and Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, Antwerp 2610, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van Damme</LastName>
                    <ForeName>Pierre</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Health Economics Research and Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, Antwerp 2610, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Molenberghs</LastName>
                    <ForeName>Geert</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>I-BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, Hasselt B-3500, Belgium; I-BioStat, Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven, Kapucijnenvoer 35, Leuven B-3000, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aerts</LastName>
                    <ForeName>Jan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>I-BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, Hasselt B-3500, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beutels</LastName>
                    <ForeName>Philippe</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Health Economics Research and Modeling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, Antwerp 2610, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Spat Spatiotemporal Epidemiol</MedlineTA>
            <NlmUniqueID>101516571</NlmUniqueID>
            <ISSNLinking>1877-5845</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D062206" MajorTopicYN="Y">Spatial Analysis</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">Disease mapping</Keyword>
            <Keyword MajorTopicYN="Y">Integrated nested Laplace approximation</Keyword>
            <Keyword MajorTopicYN="Y">Self-reporting</Keyword>
            <Keyword MajorTopicYN="Y">Spatially correlated random effects</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>5</Hour>
                <Minute>34</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33138946</ArticleId>
            <ArticleId IdType="pii">S1877-5845(20)30057-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.sste.2020.100379</ArticleId>
            <ArticleId IdType="pmc">PMC7518805</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Intern Med. 2020 May;35(5):1545-1549</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32133578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Comput Methods Programs Biomed. 2019 Apr;172:103-116</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30846296</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Apr;80(4):388-393</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32112884</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2020 Jun;145(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32179660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2016 Aug 15;35(18):3189-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26928309</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32007143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7798):265-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015508</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Methods Med Res. 2014 Dec;23(6):507-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24713158</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978945</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" VersionID="2" VersionDate="2020/10/26" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="2">33082937</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2046-1402</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <PubDate>
                        <MedlineDate>2020</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>F1000Research</Title>
                <ISOAbbreviation>F1000Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1193</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.12688/f1000research.26707.2</ELocationID>
            <Abstract>
                <AbstractText><b>Background</b>: Never before have clinical trials drawn as much public attention as those testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical research response and its evolution over the first 100 days of the pandemic. <b>Methods:</b> Descriptive analysis of planned, ongoing or completed trials by April 9, 2020 testing any intervention to treat or prevent COVID-19, systematically identified in trial registries, preprint servers, and literature databases. A survey was conducted of all trials to assess their recruitment status up to July 6, 2020. <b>Results:</b> Most of the 689 trials (overall target sample size 396,366) were small (median sample size 120; interquartile range [IQR] 60-300) but randomized (75.8%; n=522) and were often conducted in China (51.1%; n=352) or the USA (11%; n=76). 525 trials (76.2%) planned to include 155,571 hospitalized patients, and 25 (3.6%) planned to include 96,821 health-care workers. Treatments were evaluated in 607 trials (88.1%), frequently antivirals (n=144) or antimalarials (n=112); 78 trials (11.3%) focused on prevention, including 14 vaccine trials. No trial investigated social distancing. Interventions tested in 11 trials with &gt;5,000 participants were also tested in 169 smaller trials (median sample size 273; IQR 90-700). Hydroxychloroquine alone was investigated in 110 trials. While 414 trials (60.0%) expected completion in 2020, only 35 trials (4.1%; 3,071 participants) were completed by July 6. Of 112 trials with detailed recruitment information, 55 had recruited &lt;20% of the targeted sample; 27 between 20-50%; and 30 over 50% (median 14.8% [IQR 2.0-62.0%]). <b>Conclusions:</b> The size and speed of the COVID-19 clinical trials agenda is unprecedented. However, most trials were small investigating a small fraction of treatment options. The feasibility of this research agenda is questionable, and many trials may end in futility, wasting research resources. Much better coordination is needed to respond to global health threats.</AbstractText>
                <CopyrightInformation>Copyright: .. 2020 Janiaud P et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Janiaud</LastName>
                    <ForeName>Perrine</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7684-8014</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Axfors</LastName>
                    <ForeName>Cathrine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department for Women's and Children's Health, Uppsala University, Uppsala, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van't Hooft</LastName>
                    <ForeName>Janneke</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Amsterdam University Medical Center, Amsterdam University, Amsterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saccilotto</LastName>
                    <ForeName>Ramon</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Agarwal</LastName>
                    <ForeName>Arnav</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Appenzeller-Herzog</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7430-294X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>University Medical Library, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Contopoulos-Ioannidis</LastName>
                    <ForeName>Despina G</ForeName>
                    <Initials>DG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Danchev</LastName>
                    <ForeName>Valentin</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Stanford Prevention Research Center, Department of Medicine,, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dirnagl</LastName>
                    <ForeName>Ulrich</ForeName>
                    <Initials>U</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0755-6119</Identifier>
                    <AffiliationInfo>
                        <Affiliation>QUEST Center for Transforming Biomedical Research, Berlin Institute of Health, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ewald</LastName>
                    <ForeName>Hannah</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-5081-1093</Identifier>
                    <AffiliationInfo>
                        <Affiliation>University Medical Library, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gartlehner</LastName>
                    <ForeName>Gerald</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department for Evidence-based Medicine and Evaluation, Danube University Krems, Krems, Austria.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>RTI International, Research Triangle Park Laboratories, Raleigh, North Carolina, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goodman</LastName>
                    <ForeName>Steven N</ForeName>
                    <Initials>SN</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-3872-5723</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Stanford University School of Medicine, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haber</LastName>
                    <ForeName>Noah A</ForeName>
                    <Initials>NA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ioannidis</LastName>
                    <ForeName>Angeliki Diotima</ForeName>
                    <Initials>AD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Toxicology Interdepartmental Program, University of California, Los Angeles, Los Angeles, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ioannidis</LastName>
                    <ForeName>John P A</ForeName>
                    <Initials>JPA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Stanford Prevention Research Center, Department of Medicine,, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Stanford University School of Medicine, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center Berlin (METRIC-B), Berlin Institute of Health, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lythgoe</LastName>
                    <ForeName>Mark P</ForeName>
                    <Initials>MP</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8952-7639</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery &amp; Cancer, Imperial College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Wenyan</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Macleod</LastName>
                    <ForeName>Malcolm</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mali..ki</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meerpohl</LastName>
                    <ForeName>Joerg J</ForeName>
                    <Initials>JJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Evidence in Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Min</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Stanford University School of Medicine, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moher</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2434-4206</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Journalology, Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nagavci</LastName>
                    <ForeName>Blin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Evidence in Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Naudet</LastName>
                    <ForeName>Florian</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-3760-3801</Identifier>
                    <AffiliationInfo>
                        <Affiliation>CHU Rennes, Inserm, CIC 1414 [(Centre d'Investigation Clinique de Rennes)],, University of Rennes 1, Rennes, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pauli-Magnus</LastName>
                    <ForeName>Christiane</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Sullivan</LastName>
                    <ForeName>Jack W</ForeName>
                    <Initials>JW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Riedel</LastName>
                    <ForeName>Nico</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-3808-1163</Identifier>
                    <AffiliationInfo>
                        <Affiliation>QUEST Center for Transforming Biomedical Research, Berlin Institute of Health, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roth</LastName>
                    <ForeName>Jan A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sauermann</LastName>
                    <ForeName>Mandy</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schandelmaier</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmitt</LastName>
                    <ForeName>Andreas M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Deparment of Medical Oncology, University Hospital Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Speich</LastName>
                    <ForeName>Benjamin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williamson</LastName>
                    <ForeName>Paula R</ForeName>
                    <Initials>PR</Initials>
                    <AffiliationInfo>
                        <Affiliation>MRC/NIHR Trials Methodology Research Partnership, University of Liverpool, Liverpool, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hemkens</LastName>
                    <ForeName>Lars G</ForeName>
                    <Initials>LG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center at Stanford (METRICS), Stanford University,, Stanford, California, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Meta-Research Innovation Center Berlin (METRIC-B), Berlin Institute of Health, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>F1000Res</MedlineTA>
            <NlmUniqueID>101594320</NlmUniqueID>
            <ISSNLinking>2046-1402</ISSNLinking>
        </MedlineJournalInfo>
        <SupplMeshList>
            <SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
            <SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName>
                <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">clinical research agenda</Keyword>
            <Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
        </KeywordList>
        <CoiStatement>No competing interests were disclosed.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>5</Hour>
                <Minute>47</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33082937</ArticleId>
            <ArticleId IdType="doi">10.12688/f1000research.26707.2</ArticleId>
            <ArticleId IdType="pmc">PMC7539080</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>F1000Res. 2020 May 18;9:373</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32518636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 May 12;369:m1847</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32398241</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 22;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32450107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2002 Jul 17;288(3):358-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12117401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S158-S161</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32515404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jun 9;323(22):2262-2263</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32364561</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Open Forum Infect Dis. 2019 Apr 15;6(6):ofz189</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31276007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>F1000Res. 2020 Oct 2;9:1193</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33082937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):470-473</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Ethics. 2017 Dec;43(12):803-809</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28108613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2008 Jan 3;5(1):e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18177203</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Epidemiol. 2020 Sep;125:170-178</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32526460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1977 Jan 13;296(2):107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">318593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Ther. 2020 Sep;9(3):435-449</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32462545</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33137284</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>21</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>27</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2213-2619</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>12</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Lancet. Respiratory medicine</Title>
                <ISOAbbreviation>Lancet Respir Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 human challenge studies in the UK.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e96</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S2213-2600(20)30518-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(20)30518-X</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kirby</LastName>
                    <ForeName>Tony</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016433">News</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet Respir Med</MedlineTA>
            <NlmUniqueID>101605555</NlmUniqueID>
            <ISSNLinking>2213-2600</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006805" MajorTopicYN="Y">Human Experimentation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>12</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>20</Hour>
                <Minute>10</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33137284</ArticleId>
            <ArticleId IdType="pii">S2213-2600(20)30518-X</ArticleId>
            <ArticleId IdType="doi">10.1016/S2213-2600(20)30518-X</ArticleId>
            <ArticleId IdType="pmc">PMC7831781</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">33137200</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>03</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1930-613X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>186</Volume>
                    <Issue>3-4</Issue>
                    <PubDate>
                        <Year>2021</Year>
                        <Month>02</Month>
                        <Day>26</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Military medicine</Title>
                <ISOAbbreviation>Mil Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Gut Microbiota-targeted Interventions for Reducing the Incidence, Duration, and Severity of Respiratory Tract Infections in Healthy Non-elderly Adults.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e310-e318</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/milmed/usaa261</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION">Respiratory tract infections (RTI), such as those caused by influenza viruses and, more recently, the severe acute respiratory syndrome coronavirus-2, pose a significant burden to military health care systems and force readiness. The gut microbiota influences immune function, is malleable, and may provide a target for interventions aiming to reduce RTI burden. This narrative review summarizes existing evidence regarding the effectiveness of probiotics, prebiotics, and synbiotics, all of which are gut microbiota-targeted interventions, for reducing the burden of RTI in military-relevant populations (i.e., healthy non-elderly adults).</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS">A systematic search strategy was used to identify recent meta-analyses and systematic reviews of randomized controlled trials conducted in healthy non-elderly adults which examined effects of probiotics, prebiotics, or synbiotics on the incidence, duration, and/or severity of RTI, or on immune responses to vaccinations against viruses that cause RTI. Relevant randomized controlled clinical trials not included in those reports were also identified.</AbstractText>
                <AbstractText Label="RESULTS">Meta-analyses and multiple randomized controlled trials have demonstrated that certain probiotic strains may reduce the incidence, duration, and/or severity of RTI and improve immune responses to vaccination against RTI-causing pathogens in various populations including healthy non-elderly adults. Fewer randomized controlled trials have examined the effects of prebiotics or synbiotics on RTI-related outcomes in healthy non-elderly adults. Nevertheless, some studies conducted within that population and other populations have observed that certain prebiotics and synbiotics reduce the incidence, duration, and/or severity of RTI or improve immune responses to vaccinations against RTI-causing viruses. However, across all product classes, not all product formulations have shown benefit, and most have not been tested in multiple randomized controlled trials in military-relevant populations.</AbstractText>
                <AbstractText Label="CONCLUSION">Dietary supplementation with certain gut microbiota-targeted interventions, and certain probiotics in particular, may provide viable strategies for reducing RTI-related illness in military personnel. Research in military populations is warranted to fully understand the magnitude of any military health and cost benefits, and to establish definitive recommendations for use.</AbstractText>
                <CopyrightInformation>.. The Association of Military Surgeons of the United States 2020.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Karl</LastName>
                    <ForeName>J Philip</ForeName>
                    <Initials>JP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Military Nutrition Division, U.S. Army Research Institute of Environmental Medicine, Natick, MA 01760, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Mil Med</MedlineTA>
            <NlmUniqueID>2984771R</NlmUniqueID>
            <ISSNLinking>0026-4075</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008889" MajorTopicYN="N">Military Personnel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019936" MajorTopicYN="Y">Probiotics</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>17</Hour>
                <Minute>14</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33137200</ArticleId>
            <ArticleId IdType="pii">5909704</ArticleId>
            <ArticleId IdType="doi">10.1093/milmed/usaa261</ArticleId>
            <ArticleId IdType="pmc">PMC7665594</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">33134200</PMID>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2248-2997</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Germs</Title>
                <ISOAbbreviation>Germs</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 (SARS-CoV-2) pandemic: fears, facts and preventive measures.</ArticleTitle>
            <Pagination>
                <MedlinePgn>218-228</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.18683/germs.2020.1208</ELocationID>
            <Abstract>
                <AbstractText>The aim of this review is to give a synopsis on the coronavirus disease 2019 (COVID-19) pandemic, with major focus on the preventive measures. Ever since the influenza pandemic of 1918, and the second world war of (1939-1945), the world has not been faced with a common problem in recent memory like the COVID-19 pandemic. The unprecedented COVID-19 pandemic is caused by infection with a viral pathogen, the nascent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and is characterized by respiratory failure in severe cases. The communicability period of COVID-19 varies, but it is usually between 2-14 days, and the major signs and symptoms of COVID-19 are high temperature (fever), severe and consistent cough, and serious breathing problems in severe cases, however, complications result in the serious inflammation of the lungs, and organ malfunction occurs in patients with comorbidities and health conditions especially diabetes, heart disease and obesity. With high virulence and contagious nature of SARS-CoV-2, over 11.4 million confirmed cases and over 533,780 deaths have occurred as a result of COVID-19 globally, with over 6.1 million recoveries as of 6<sup>th</sup> July 2020. Presently, there is no known cure for COVID-19, however, remdesivir has been approved for emergency use for the treatment of COVID-19 patients by the Food and Drug Administration, a United States federal regulatory body (FDA), while various clinical trial treatments and vaccines are being tried globally. The world is faced with containing the spread of the infection, and this review revealed that thorough hand washing with antiseptic soap and running water and usage of alcohol hand sanitizer, frequent surfaces cleaning, strict adherence to social distancing, regular respiratory hygiene, wearing of protective face masks, frequent testing, self-isolation, quarantine and rigorous contact tracing will help to prevent further spread, and control the transmission of the viral pathogen. It is however strongly recommended that only the strict compliance to the mitigative and preventive measures provided above will yield the desired results in the prevention, management and control of the COVID-19 pandemic.</AbstractText>
                <CopyrightInformation>GERMS.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ayenigbara</LastName>
                    <ForeName>Israel Oluwasegun</ForeName>
                    <Initials>IO</Initials>
                    <AffiliationInfo>
                        <Affiliation>M Ed, Doctoral Candidate, School and Community Health Education Unit, Department of Health Education, University of Ibadan, Ajibode street number 022, postal code 200284, Ibadan, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adeleke</LastName>
                    <ForeName>Olasunkanmi Rowland</ForeName>
                    <Initials>OR</Initials>
                    <AffiliationInfo>
                        <Affiliation>M Ed, Department of Human Kinetics and Health Education, Adekunle Ajasin University Akungba-Akoko, Adefarati street number 001, postal address 342111, Ondo State, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ayenigbara</LastName>
                    <ForeName>George Omoniyi</ForeName>
                    <Initials>GO</Initials>
                    <AffiliationInfo>
                        <Affiliation>PhD, Department of Human Kinetics and Health Education, Adekunle Ajasin University Akungba-Akoko, Adefarati street number 001, postal address 342111, Ondo State, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adegboro</LastName>
                    <ForeName>Joseph Sunday</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>PhD, Department of Human Kinetics and Health Education, Adekunle Ajasin University Akungba-Akoko, Adefarati street number 001, postal address 342111, Ondo State, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Olofintuyi</LastName>
                    <ForeName>Oluwaseyi Oye</ForeName>
                    <Initials>OO</Initials>
                    <AffiliationInfo>
                        <Affiliation>BSc Ed, Department of Human Kinetics and Health Education, Adekunle Ajasin University Akungba-Akoko, Adefarati street number 001, postal address 342111, Ondo State, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Romania</Country>
            <MedlineTA>Germs</MedlineTA>
            <NlmUniqueID>101596099</NlmUniqueID>
            <ISSNLinking>2248-2997</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">control measures</Keyword>
            <Keyword MajorTopicYN="N">mitigation</Keyword>
            <Keyword MajorTopicYN="N">prevention</Keyword>
        </KeywordList>
        <CoiStatement>Conflicts of interest: All authors ... none to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>20</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33134200</ArticleId>
            <ArticleId IdType="doi">10.18683/germs.2020.1208</ArticleId>
            <ArticleId IdType="pii">germs.2020.1208</ArticleId>
            <ArticleId IdType="pmc">PMC7572217</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Anaesthesia. 2020 Jul;75(7):920-927</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32246849</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 21;395(10228):931-934</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32164834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hosp Infect. 2020 Mar;104(3):246-251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32035997</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 12;323(18):1837-1838</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32215590</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Autoimmun. 2020 May;109:102433</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113704</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mil Med Res. 2020 Feb 6;7(1):4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32029004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Res. 2020 Jul;157:104859</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32360480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Med Suisse. 2020 Apr 29;16(N.. 691-2):835-838</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32348047</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Apr;25(13):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32265005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pathogens. 2020 Mar 23;9(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32210130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 May;8(5):434-436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32203710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 26;382(13):1199-1207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31995857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Surg. 2020 May;77:217</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32305321</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Med Chem. 2020 Sep 1;201:112527</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32563812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):170-172</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32164080</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Microbiol. 2020 Apr;5(4):562-569</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32094589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Oct;92(10):1745-1746</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32267002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jul;583(7815):282-285</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32218527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trop Med Int Health. 2020 Mar;25(3):278-280</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32052514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cent Asian J Glob Health. 2020 Apr 1;9(1):e466</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33062403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ned Tijdschr Geneeskd. 2020 Apr 8;164:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32395966</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Jul;92(7):849-855</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32266990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can J Anaesth. 2020 Jul;67(7):893-894</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32189218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anesth Analg. 2020 Jul;131(1):37-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32217947</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33133071</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>12</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1664-3224</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in immunology</Title>
                <ISOAbbreviation>Front Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.</ArticleTitle>
            <Pagination>
                <MedlinePgn>561851</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2020.561851</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Usmani</LastName>
                    <ForeName>Salman Sadullah</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raghava</LastName>
                    <ForeName>Gajendra P S</ForeName>
                    <Initials>GPS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Immunol</MedlineTA>
            <NlmUniqueID>101560960</NlmUniqueID>
            <ISSNLinking>1664-3224</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">COVID-19</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">coronavirus</Keyword>
            <Keyword MajorTopicYN="Y">immunoinformatic</Keyword>
            <Keyword MajorTopicYN="Y">vaccine candidates</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>15</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33133071</ArticleId>
            <ArticleId IdType="doi">10.3389/fimmu.2020.561851</ArticleId>
            <ArticleId IdType="pmc">PMC7550622</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2019 Sep 1;35(17):3020-3027</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30657872</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr HIV Res. 2013 Jul;11(5):421-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24191936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W202-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16844994</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2020 Jun 05;11:1120</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32582200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2005 Mar 18;23(17-18):2273-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15755610</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2017 Nov 17;358(6365):929-932</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29097492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2019 Sep;19(9):1013-1022</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31351922</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Cell Infect Microbiol. 2018 Feb 15;8:44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29497604</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 2020 Jun 1;217(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32353870</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):593-604</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32347054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2020 Apr 10;21(7):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32290293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2006 Apr 24;24(17):3624-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16497416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 21;382(21):1969-1973</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32227757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2010 Mar 30;399(1):120-128</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20110095</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2008 Mar 20;26(13):1644-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18289745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Rev. 2015 Nov;268(1):340-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26497532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2013 Dec;132(6):1263-76; quiz 1277</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23915713</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Dev Immunol. 2013;2013:263952</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24489573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2020 Jun 16;94(13):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32303592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32702298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 2008 Sep;89(Pt 9):2136-2146</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18753223</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antivir Ther. 2007;12(7):1107-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18018769</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Leukoc Biol. 2020 Oct 11;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33040384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2016 Mar 08;6:22843</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26953092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pharmacol. 2020 Feb 20;11:54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32153395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Apr 30;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32355243</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7821):353-363</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32659783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Nov 29;9(1):17923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31784686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jul 3;369(6499):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32376603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JCI Insight. 2019 Feb 21;4(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30830861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2011 Dec;85(23):12201-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21937658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2020 Feb 25;12(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32106567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2020 Jun 1;36(11):3350-3356</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32145017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25073113</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brief Bioinform. 2017 May 1;18(3):467-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27016393</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Toxicol. 2020 Jul;16(3):284-294</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32356252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2020 Jun;46(6):1294-1297</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32253449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):797-801</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15642942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Feb 17;7:42851</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28211521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jun 6;54(6):614-619</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32234130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viral Immunol. 1996;9(1):51-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8733920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Sep 13;8(9):e73957</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24058508</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jun;20(6):347-348</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32346094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32183941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jun;20(6):339-341</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32317716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2011 Oct;85(20):10582-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21775467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2016 Aug;14(8):523-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27344959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(4):e35421</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22536382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Model. 2014 Jun;20(6):2278</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24878803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viral Immunol. 2003;16(1):69-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12725690</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 May;92(5):495-500</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32022276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Discov. 2020 May 4;6:31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32377375</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2004 Apr 1;428(6982):561-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15024391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2007 Sep 28;25(39-40):6981-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17709158</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32192578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Protein Chem Struct Biol. 2018;112:221-263</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29680238</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1979 Oct;140(4):527-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">117061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2015 May;479-480:247-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25791336</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32202240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Ther. 2020 Apr 23;:1-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32328406</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">33132155</PMID>
        <DateCompleted>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1559-2030</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>99</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>12</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Contemporary clinical trials</Title>
                <ISOAbbreviation>Contemp Clin Trials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country.</ArticleTitle>
            <Pagination>
                <MedlinePgn>106189</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1551-7144(20)30267-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cct.2020.106189</ELocationID>
            <Abstract>
                <AbstractText>Starting from historic reflections, the current SARS-CoV-2 induced COVID-19 pandemic is examined from various perspectives, in terms of what it implies for the implementation of non-pharmaceutical interventions, the modeling and monitoring of the epidemic, the development of early-warning systems, the study of mortality, prevalence estimation, diagnostic and serological testing, vaccine development, and ultimately clinical trials. Emphasis is placed on how the pandemic had led to unprecedented speed in methodological and clinical development, the pitfalls thereof, but also the opportunities that it engenders for national and international collaboration, and how it has simplified and sped up procedures. We also study the impact of the pandemic on clinical trials in other indications. We note that it has placed biostatistics, epidemiology, virology, infectiology, and vaccinology, and related fields in the spotlight in an unprecedented way, implying great opportunities, but also the need to communicate effectively, often amidst controversy.</AbstractText>
                <CopyrightInformation>Copyright .. 2020 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Molenberghs</LastName>
                    <ForeName>Geert</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Belgium; Interuniversity Institute for Biostatistics and statistical Bioinformatics, KU Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buyse</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Belgium; International Drug Development Institute, Belgium; CluePoints, Belgium. Electronic address: marc.buyse@iddi.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abrams</LastName>
                    <ForeName>Steven</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Belgium; Global Health Institute, Department of Epidemiology and Social Medicine, University of Antwerp, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hens</LastName>
                    <ForeName>Niel</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Belgium; Centre for Health Economics Research and Modelling of Infectious Diseases, University of Antwerp, Belgium; Vaccine &amp; Infectious Disease Institute, University of Antwerp, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beutels</LastName>
                    <ForeName>Philippe</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Health Economics Research and Modelling of Infectious Diseases, University of Antwerp, Belgium; Vaccine &amp; Infectious Disease Institute, University of Antwerp, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Faes</LastName>
                    <ForeName>Christel</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Verbeke</LastName>
                    <ForeName>Geert</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Belgium; Interuniversity Institute for Biostatistics and statistical Bioinformatics, KU Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van Damme</LastName>
                    <ForeName>Pierre</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Health Economics Research and Modelling of Infectious Diseases, University of Antwerp, Belgium; Vaccine &amp; Infectious Disease Institute, University of Antwerp, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goossens</LastName>
                    <ForeName>Herman</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Microbiology, University of Antwerp, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Neyens</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Belgium; Interuniversity Institute for Biostatistics and statistical Bioinformatics, KU Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Herzog</LastName>
                    <ForeName>Sereina</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Health Economics Research and Modelling of Infectious Diseases, University of Antwerp, Belgium; Vaccine &amp; Infectious Disease Institute, University of Antwerp, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Theeten</LastName>
                    <ForeName>Heidi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Health Economics Research and Modelling of Infectious Diseases, University of Antwerp, Belgium; Vaccine &amp; Infectious Disease Institute, University of Antwerp, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pepermans</LastName>
                    <ForeName>Koen</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Health Economics Research and Modelling of Infectious Diseases, University of Antwerp, Belgium; Vaccine &amp; Infectious Disease Institute, University of Antwerp, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abad</LastName>
                    <ForeName>Ariel Alonso</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interuniversity Institute for Biostatistics and statistical Bioinformatics, KU Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van Keilegom</LastName>
                    <ForeName>Ingrid</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>ORSTAT, Faculty of Economy and Business, KU Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Speybroeck</LastName>
                    <ForeName>Niko</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Health and Society, UC Louvain, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Legrand</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Statistics, Biostatistics and Actuarial Sciences, UC Louvain, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>De Buyser</LastName>
                    <ForeName>Stefanie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Ghent, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hulstaert</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Belgian Health Care Knowledge Center (KCE), Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Contemp Clin Trials</MedlineTA>
            <NlmUniqueID>101242342</NlmUniqueID>
            <ISSNLinking>1551-7144</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056808" MajorTopicYN="N">Biostatistics</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName>
                <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004812" MajorTopicYN="Y">Epidemiologic Methods</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058015" MajorTopicYN="N">Health Communication</DescriptorName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D032521" MajorTopicYN="N">Immunity, Herd</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011639" MajorTopicYN="N">Public Opinion</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
                <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Antiviral therapy</Keyword>
            <Keyword MajorTopicYN="Y">Data sharing</Keyword>
            <Keyword MajorTopicYN="Y">Diagnostic testing</Keyword>
            <Keyword MajorTopicYN="Y">Factorial designs</Keyword>
            <Keyword MajorTopicYN="Y">Infection fatality rate</Keyword>
            <Keyword MajorTopicYN="Y">Mathematical epidemiology</Keyword>
            <Keyword MajorTopicYN="Y">Mathematical modeling</Keyword>
            <Keyword MajorTopicYN="Y">Mortality</Keyword>
            <Keyword MajorTopicYN="Y">Non-pharmaceutical intervention</Keyword>
            <Keyword MajorTopicYN="Y">Nowcasting</Keyword>
            <Keyword MajorTopicYN="Y">Platform trials</Keyword>
            <Keyword MajorTopicYN="Y">Pragmatic trials</Keyword>
            <Keyword MajorTopicYN="Y">Prevalence</Keyword>
            <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="Y">Vaccine development</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>10</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2021</Year>
                <Month>1</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>5</Hour>
                <Minute>51</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">33132155</ArticleId>
            <ArticleId IdType="pii">S1551-7144(20)30267-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cct.2020.106189</ArticleId>
            <ArticleId IdType="pmc">PMC7581408</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2020 Sep 10;383(11):1071-1077</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32706958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Immunol. 2020 Jul 17;5(49):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32680954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JMIR Public Health Surveill. 2020 May 29;6(2):e19279</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32449686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2012 Dec 30;31(30):4269-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22826199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Apr;93:284-286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32145466</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2007 May 1;104(18):7588-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17416677</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2018 Nov 1;178(11):1451-1457</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30264133</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2007 Jan 30;26(2):237-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17139691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Trials. 2019 Oct;16(5):539-546</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31347390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2018 Feb 6;319(5):483-494</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29411037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2017 Oct 15;36(23):3603-3604</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28675923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Evid Based Med. 2020 Feb;13(1):3-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32048815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Aug 14;369(6505):846-849</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32576668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Aug 11;324(6):543-545</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32717043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Immunol. 2004 Oct;16(10):1423-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15314040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Hum Behav. 2020 May;4(5):460-471</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32355299</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biometrics. 2009 Dec;65(4):1270-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19210734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Nov;26(11):1671-1672</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32963376</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Oncol. 2020 Jul;25(7):1207-1214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32577951</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32584464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 13;382(7):674-678</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32053307</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 1;368(6490):476-477</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32327600</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Jun;25(22):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32524949</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 19;323(19):1893-1894</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32297897</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Dec 13;9(1):19122</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31836780</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Osong Public Health Res Perspect. 2020 Apr;11(2):74-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32257772</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32031570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2016 Jan 15;11(1):e0147172</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26771513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 Aug;26(8):1200-1204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32555424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Glob Health. 2020 Apr;8(4):e488-e496</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32119825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 21;395(10228):931-934</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32164834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Environ Res Public Health. 2020 Oct 17;17(20):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33080869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Apr;8(4):321</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32192583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2019 Oct 11;14(10):e0223832</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31603953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epidemics. 2015 Dec;13:1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26616037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Elife. 2020 Sep 07;9:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32894217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Aug;584(7820):257-261</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32512579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Spat Spatiotemporal Epidemiol. 2020 Nov;35:100379</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33138946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Microbiol. 2020 Oct;5(10):1299-1305</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32651556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJR Am J Roentgenol. 2020 Jun;214(6):1280-1286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32130038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pers Individ Dif. 2020 Nov 1;166:110220</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32834279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trials. 2014 Nov 29;15:470</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25433679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Public Health. 2013 Oct;58(5):791-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23263198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 May;92(5):476-478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32056235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Heart J. 2017 Jun 1;38(21):1632-1637</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28329235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Apr 7;369:m1328</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32265220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chronic Dis. 1967 Aug;20(8):637-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4860352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Mar 26;382(13):1268-1269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 22;368(6493):860-868</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32291278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antiviral Res. 2010 Jan;85(1):1-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20018391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2006 Jul;80(14):7270-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16809333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Vet Entomol. 2012 Dec;26(4):361-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22486773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 Feb 17;9(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32079150</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Aug;20(8):e192-e197</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32539990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 22;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32450107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Euro Surveill. 2020 Jul;25(29):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32720639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Feb 20;382(8):692-694</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31978293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Dis Poverty. 2020 Feb 28;9(1):24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32111262</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2020 Jul;20(7):758-759</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32330441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Aug 4;324(5):458-459</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32609308</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 May;26(5):672-675</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32296168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Jul 1;370:m2516</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32611558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):204-208</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32352314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Jul 31;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32735313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2009 Sep 30;28(22):2769-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19598148</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Trials. 2015 Apr;12(2):102-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25649106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Comput Biol. 2011 Feb 10;7(2):e1001076</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21347316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Aug 4;324(5):460-470</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32492084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jan;577(7792):605-607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31992880</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12781533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Med. 2020 Jun 25;18(1):191</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32586336</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mo Med. 2020 May-Jun;117(3):184-195</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32636542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2019 Aug;25(8):1178-1180</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31227810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2003 Jan 15;22(1):19-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12486749</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Law Biosci. 2020 May 28;7(1):lsaa034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32728470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32445440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J R Soc Interface. 2007 Feb 22;4(12):155-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17254982</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Med. 2020 Sep 9;18(1):286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32900372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 2020 May 26;58(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32245835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Adv. 2020 Nov 20;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">33219112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 May 12;323(18):1843-1844</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32159775</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Trials. 2017 Oct;14(5):499-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28641461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2020 Sep 17;11(1):4704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32943637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jul 17;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32678530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32105632</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Sep;8(9):885-894</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32717210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2019 Apr 23;321(16):1610-1620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31012939</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
